BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Liver transplantation. J Hepatol. 2016;64:433-485. [PMID: 26597456 DOI: 10.1016/j.jhep.2015.10.006] [Cited by in Crossref: 390] [Cited by in F6Publishing: 292] [Article Influence: 55.7] [Reference Citation Analysis]
Number Citing Articles
1 Xiao J, Yong JN, Ng CH, Syn N, Lim WH, Tan DJH, Tan EY, Huang D, Wong RC, Chew NWS, Tan EXX, Noureddin M, Siddiqui MS, Muthiah MD. A Meta-Analysis and Systematic Review on the Global Prevalence, Risk Factors, and Outcomes of Coronary Artery Disease in Liver Transplantation Recipients. Liver Transpl 2021. [PMID: 34626045 DOI: 10.1002/lt.26331] [Reference Citation Analysis]
2 Reau N. Pregnancy after liver transplantation: Can renal function quell the fear? Liver Transpl 2018;24:583-4. [PMID: 29626391 DOI: 10.1002/lt.25070] [Reference Citation Analysis]
3 Willuweit K, Frey A, Hörster A, Saner F, Herzer K. Real-World Administration of Once-Daily MeltDose® Prolonged-Release Tacrolimus (LCPT) Allows for Dose Reduction of Tacrolimus and Stabilizes Graft Function Following Liver Transplantation. J Clin Med 2020;10:E124. [PMID: 33396492 DOI: 10.3390/jcm10010124] [Reference Citation Analysis]
4 Couto I, Victoria M, Veloso VG, Rodrigues L, Grinsztejn B, Lacerda M, Victoria F, Perazzo H. Prevalence and predictors for compensated Advanced Chronic Liver Disease (c-ACLD) in patients with chronic Hepatitis Delta Virus (HDV) infection. PLoS One. 2017;12:e0174453. [PMID: 28329027 DOI: 10.1371/journal.pone.0174453] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
5 Al-Ameri AAM, Wei X, Liu P, Lin L, Shao Z, Xie H, Zhou L, Zheng S, Xu X. Prediction of Early Recurrence of Hepatocellular Carcinoma in Patients with Cirrhosis Who Had Received Deceased Donor Liver Transplantation: A Multicenter Study. Ann Transplant 2019;24:489-98. [PMID: 31427563 DOI: 10.12659/AOT.917296] [Reference Citation Analysis]
6 Daniel KE, Matthews LA, Deiss-Yehiely N, Myers J, Garvey M, Rice JP, Eickhoff J, Lucey MR. Psychosocial Assessment Rather Than Severity of Liver Failure Dominates Selection for Liver Transplantation in Patients With Alcohol-Related Liver Disease. Liver Transpl 2021. [PMID: 34596955 DOI: 10.1002/lt.26324] [Reference Citation Analysis]
7 Fortea JI, Cuadrado A, Puente Á, Álvarez Fernández P, Huelin P, Álvarez Tato C, García Carrera I, Cobreros M, Cagigal Cobo ML, Calvo Montes J, Ruiz de Alegría Puig C, Rodríguez SanJuán JC, Castillo Suescun FJ, Fernández Santiago R, Echeverri Cifuentes JA, Casafont F, Crespo J, Fábrega E. Is Routine Prophylaxis Against Pneumocystis jirovecii Needed in Liver Transplantation? A Retrospective Single-Centre Experience and Current Prophylaxis Strategies in Spain. J Clin Med 2020;9:E3573. [PMID: 33171962 DOI: 10.3390/jcm9113573] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
8 Nordin A, Åberg F, Pukkala E, Pedersen CR, Storm HH, Rasmussen A, Bennet W, Olausson M, Wilczek H, Ericzon BG, Tretli S, Line PD, Karlsen TH, Boberg KM, Isoniemi H. Decreasing incidence of cancer after liver transplantation-A Nordic population-based study over 3 decades. Am J Transplant 2018;18:952-63. [PMID: 28925583 DOI: 10.1111/ajt.14507] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
9 Egeli T, Unek T, Agalar C, Ozbilgin M, Derici S, Cevlik AD, Akarsu M, Ellidokuz H, Astarcioglu I. Survival Outcomes After Liver Transplantation in Elderly Patients: A Single-Center Retrospective Analysis. Transplant Proc 2019;51:1143-6. [PMID: 31101188 DOI: 10.1016/j.transproceed.2019.01.090] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Burra P, Belli LS, Ginanni Corradini S, Volpes R, Marzioni M, Giannini E, Toniutto P. Common issues in the management of patients in the waiting list and after liver transplantation. Dig Liver Dis 2017;49:241-53. [PMID: 28096056 DOI: 10.1016/j.dld.2016.12.027] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
11 Takakusagi S, Shimizu M, Yokoyama Y, Kizawa K, Marubashi K, Kosone T, Sato K, Kakizaki S, Takagi H, Uraoka T. Hepatitis C virus-associated decompensated liver cirrhosis with refractory hepatic encephalopathy successfully treated by balloon-occluded retrograde transvenous obliteration after sofosbuvir/velpatasvir. Clin J Gastroenterol 2020;13:1303-9. [PMID: 32914297 DOI: 10.1007/s12328-020-01229-x] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 von Einsiedel J, Thölking G, Wilms C, Vorona E, Bokemeyer A, Schmidt HH, Kabar I, Hüsing-Kabar A. Conversion from Standard-Release Tacrolimus to MeltDose® Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation. J Clin Med 2020;9:E1654. [PMID: 32492783 DOI: 10.3390/jcm9061654] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 German MN, Eccleston JL, Tamez DA, Remington PL, Lucey MR. Internet Published Policies Regarding Liver Transplant Eligibility and Substance Use in United States Transplant Centers. Hepatol Commun 2020;4:1717-24. [PMID: 33163840 DOI: 10.1002/hep4.1591] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Dolnikov S, Adam R, Cherqui D, Allard MA. Liver transplantation in elderly patients: what do we know at the beginning of 2020? Surg Today 2020;50:533-9. [PMID: 32279191 DOI: 10.1007/s00595-020-01996-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Majumdar A, Tsochatzis EA. Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease. Metabolism 2020;111:154291. [DOI: 10.1016/j.metabol.2020.154291] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Shafiekhani M, Karimzadeh I, Nikeghbalian S, Firoozifar M, Pouladfar G, Vazin A. Comparison of Ceftizoxime Plus Ampicillin-Sulbactam versus Gentamicin Plus Ampicillin-Sulbactam in the Prevention of Post-Transplant Early Bacterial Infections in Liver Transplant Recipients: A Randomized Controlled Trial. Infect Drug Resist 2020;13:89-98. [PMID: 32021323 DOI: 10.2147/IDR.S222934] [Reference Citation Analysis]
17 Tai D, Dhar A, Yusuf A, Marshall A, O'beirne J, Patch D, Tsochatzis E, Alexander G, Portal J, Thalheimer U, Thorburn D, Kallis Y, Westbrook R. The Royal Free Hospital ‘hub-and-spoke network model’ delivers effective care and increased access to liver transplantation. Public Health 2018;154:164-71. [DOI: 10.1016/j.puhe.2017.10.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
18 Bittersohl H, Schniedewind B, Christians U, Luppa PB. A simple and highly sensitive on-line column extraction liquid chromatography-tandem mass spectrometry method for the determination of protein-unbound tacrolimus in human plasma samples. Journal of Chromatography A 2018;1547:45-52. [DOI: 10.1016/j.chroma.2018.03.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
19 Zanetto A, Shalaby S, Gambato M, Germani G, Senzolo M, Bizzaro D, Russo FP, Burra P. New Indications for Liver Transplantation. J Clin Med 2021;10:3867. [PMID: 34501314 DOI: 10.3390/jcm10173867] [Reference Citation Analysis]
20 Cernigliaro V, Peluso R, Zedda B, Silengo L, Tolosano E, Pellicano R, Altruda F, Fagoonee S. Evolving Cell-Based and Cell-Free Clinical Strategies for Treating Severe Human Liver Diseases. Cells 2020;9:E386. [PMID: 32046114 DOI: 10.3390/cells9020386] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
21 Liu S, Miao J, Shi X, Wu Y, Jiang C, Zhu X, Wu X, Ding Y, Xu Q. Risk Factors for Post-Transplant Death in Donation after Circulatory Death Liver Transplantation. J Invest Surg 2018;31:393-401. [PMID: 28829664 DOI: 10.1080/08941939.2017.1339152] [Reference Citation Analysis]
22 Kelava T, Turcic P, Markotic A, Ostojic A, Sisl D, Mrzljak A. Importance of genetic polymorphisms in liver transplantation outcomes. World J Gastroenterol 2020; 26(12): 1273-1285 [PMID: 32256016 DOI: 10.3748/wjg.v26.i12.1273] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Joshi D, Gupta N, Samyn M, Deheragoda M, Dobbels F, Heneghan MA. The management of childhood liver diseases in adulthood. Journal of Hepatology 2017;66:631-44. [DOI: 10.1016/j.jhep.2016.11.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
24 Schlegel A, Dutkowski P. Impact of Machine Perfusion on Biliary Complications after Liver Transplantation. Int J Mol Sci 2018;19:E3567. [PMID: 30424553 DOI: 10.3390/ijms19113567] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
25 Chen X, Zhang Y, Yu J. Symptom Experience and Related Predictors in Liver Transplantation Recipients. Asian Nurs Res (Korean Soc Nurs Sci) 2021;15:8-14. [PMID: 33188944 DOI: 10.1016/j.anr.2020.11.001] [Reference Citation Analysis]
26 Filipec Kanizaj T, Mijic M. Inflammatory bowel disease in liver transplanted patients. World J Gastroenterol 2017; 23(18): 3214-3227 [PMID: 28566881 DOI: 10.3748/wjg.v23.i18.3214] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
27 Jeong WK. Clinical implication of hepatic volumetry for living donor liver transplantation. Clin Mol Hepatol 2018;24:51-3. [PMID: 29580036 DOI: 10.3350/cmh.2018.1003] [Reference Citation Analysis]
28 Cesaretti M, Zarzavajian Le Bian A, Moccia S, Iannelli A, Schiavo L, Diaspro A. From deceased to bioengineered graft: New frontiers in liver transplantation. Transplant Rev (Orlando) 2019;33:72-6. [PMID: 30598370 DOI: 10.1016/j.trre.2018.12.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
29 Talakić E, Janek E, Mikalauskas S, Schemmer P. Liver Transplantation in Malignancies: A Comprehensive and Systematic Review on Oncological Outcome. Visc Med 2021;37:302-14. [PMID: 34540947 DOI: 10.1159/000517328] [Reference Citation Analysis]
30 Millson C, Considine A, Cramp ME, Holt A, Hubscher S, Hutchinson J, Jones K, Leithead J, Masson S, Menon K, Mirza D, Neuberger J, Prasad R, Pratt A, Prentice W, Shepherd L, Simpson K, Thorburn D, Westbrook R, Tripathi D. Adult liver transplantation: A UK clinical guideline - part 1: pre-operation. Frontline Gastroenterol 2020;11:375-84. [PMID: 32879721 DOI: 10.1136/flgastro-2019-101215] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
31 Shah N, Eyre TA, Tucker D, Kassam S, Parmar J, Featherstone C, Andrews P, Asgari E, Chaganti S, Menne TF, Fox CP, Pettit S, Suddle A, Bowles KM; Haemato-Oncology Task Force of the British Society for Haematology and the British Transplantation Society. Front-line management of post-transplantation lymphoproliferative disorder in adult solid organ recipient patients - A British Society for Haematology Guideline. Br J Haematol 2021;193:727-40. [PMID: 33877688 DOI: 10.1111/bjh.17421] [Reference Citation Analysis]
32 Kahn J, Schemmer P. Control of Ischemia-Reperfusion Injury in Liver Transplantation: Potentials for Increasing the Donor Pool. Visc Med 2018;34:444-8. [PMID: 30675491 DOI: 10.1159/000493889] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
33 Zhang QY, Zhang QF, Zhang DZ. The Impact of Steatosis on the Outcome of Liver Transplantation: A Meta-Analysis. Biomed Res Int 2019;2019:3962785. [PMID: 31218224 DOI: 10.1155/2019/3962785] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
34 Pandya K, Sastry V, Panlilio MT, Yip TCF, Salimi S, West C, Virtue S, Wells M, Crawford M, Pulitano C, Strasser SI, McCaughan GW, Majumdar A, Liu K. Differential Impact of Extended Criteria Donors After Brain Death or Circulatory Death in Adult Liver Transplantation. Liver Transpl 2020;26:1603-17. [PMID: 32750732 DOI: 10.1002/lt.25859] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
35 Melamed KH, Dai D, Cuk N, Markovic D, Follett R, Wang T, Lopez RC, Shirali AS, Yanagawa J, Busuttil R, Kaldas F, Barjaktarevic I. Preoperative Trapped Lung Is Associated With Increased Mortality After Orthotopic Liver Transplantation. Prog Transplant 2021;31:47-54. [PMID: 33280518 DOI: 10.1177/1526924820978604] [Reference Citation Analysis]
36 Amado V, Rodríguez-Perálvarez M, Ferrín G, De la Mata M. Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria. J Hepatocell Carcinoma 2019;6:1-10. [PMID: 30613572 DOI: 10.2147/JHC.S174549] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
37 Gil E, Kim JM, Jeon K, Park H, Kang D, Cho J, Suh GY, Park J. Recipient Age and Mortality After Liver Transplantation: A Population-based Cohort Study. Transplantation. 2018;102:2025-2032. [PMID: 30153223 DOI: 10.1097/tp.0000000000002246] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 8.3] [Reference Citation Analysis]
38 So WZ, Tan FL, Tan DJH, Ng CH, Yong JN, Syn N, Tang ASP, Wong RC, Lin W, Tan EXX, Huang DQ, Dan YY, Chew NWS, Siddiqui MS, Muthiah MD. A systematic review and meta-analysis on the impact of pre-existing and new-onset atrial fibrillation on outcomes before and after liver transplantation. Dig Liver Dis 2021:S1590-8658(21)00851-3. [PMID: 34896025 DOI: 10.1016/j.dld.2021.11.011] [Reference Citation Analysis]
39 Cottone C, Pena Polanco NA, Bhamidimarri KR. Transplant of Elderly Patients: Is There an Upper Age Cutoff? Clin Liver Dis 2021;25:209-27. [PMID: 33978580 DOI: 10.1016/j.cld.2020.09.001] [Reference Citation Analysis]
40 Marambio A, Tuñon JMC, Gómez LMM, Martínez JMA, Bellido CB, Artacho GS, Franco CC, Pulido LB, Ruiz FJP, Bravo MAG. Intraoperative Portal Vein Flow > 123 mL/min Per 100 g Predicts a Better Survival of Patients After Liver Transplantation. Transplant Proc 2018;50:3582-6. [PMID: 30522858 DOI: 10.1016/j.transproceed.2018.06.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
41 Tao Y, Wu D, Zhou L, Chen E, Liu C, Tang X, Jiang W, Han N, Li H, Tang H. Present and Future Therapies for Chronic Hepatitis B. Adv Exp Med Biol. 2020;1179:137-186. [PMID: 31741336 DOI: 10.1007/978-981-13-9151-4_6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
42 Puia-Negulescu S, Lebossé F, Mabrut JY, Muller X, Rossignol G, Antonini T, Erard D, Radenne S, Guillet M, Souquet JC, Mohkam K, Lesurtel M. Liver Transplantation for Colorectal Liver Metastases: Current Management and Future Perspectives. Int J Mol Sci 2021;22:3093. [PMID: 33803503 DOI: 10.3390/ijms22063093] [Reference Citation Analysis]
43 Levy C, Lassailly G, El Amrani M, Vincent F, Delhaye C, Meurice T, Boleslawski E, Millet G, Ningarhari M, Truant S, Louvet A, Mathurin P, Lebuffe G, Pruvot FR, Dharancy S. Transcatheter aortic valve replacement (TAVR) as bridge therapy restoring eligibility for liver transplantation in cirrhotic patients. Am J Transplant 2020;20:2567-70. [PMID: 32347626 DOI: 10.1111/ajt.15955] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Testino G, Vignoli T, Patussi V, Scafato E, Caputo F; SIA board (Appendix A) and the external expert supervisors (Appendix B). Management of end-stage alcohol-related liver disease and severe acute alcohol-related hepatitis: position paper of the Italian Society on Alcohol (SIA). Dig Liver Dis 2020;52:21-32. [PMID: 31757596 DOI: 10.1016/j.dld.2019.09.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
45 Pflüger MJ, Maurer MM, Hillebrandt KH, Andreou A, Geisel D, Schmelzle M, Pratschke J, Eurich D. Intrahepatic De Novo Tumors in Liver Recipients are Highly Associated With Recurrent Viral Hepatitis. J Clin Exp Hepatol 2021;11:435-42. [PMID: 34276150 DOI: 10.1016/j.jceh.2020.11.003] [Reference Citation Analysis]
46 Bittermann T, Hubbard RA, Lewis JD, Goldberg DS. The use of induction therapy in liver transplantation is highly variable and is associated with posttransplant outcomes. Am J Transplant 2019;19:3319-27. [PMID: 31243887 DOI: 10.1111/ajt.15513] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
47 Karlsen TH, Folseraas T, Thorburn D, Vesterhus M. Primary sclerosing cholangitis - a comprehensive review. J Hepatol. 2017;67:1298-1323. [PMID: 28802875 DOI: 10.1016/j.jhep.2017.07.022] [Cited by in Crossref: 244] [Cited by in F6Publishing: 209] [Article Influence: 48.8] [Reference Citation Analysis]
48 Faitot F, Besch C, Battini S, Ruhland E, Onea M, Addeo P, Woehl-Jaeglé ML, Ellero B, Bachellier P, Namer IJ. Impact of real-time metabolomics in liver transplantation: Graft evaluation and donor-recipient matching. J Hepatol 2018;68:699-706. [PMID: 29191459 DOI: 10.1016/j.jhep.2017.11.022] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
49 Koc ÖM, Pierco M, Remans K, Van den Hende T, Verbeek J, Van Malenstein H, Van der Merwe S, Robaeys G, Monbaliu D, Pirenne J, Van den Bosch B, Dobbels F, Nevens F. Telemedicine based remote monitoring after liver transplantation: Feasible in a select group and a more stringent control of immunosuppression. Clin Transplant 2021;:e14494. [PMID: 34596918 DOI: 10.1111/ctr.14494] [Reference Citation Analysis]
50 Cañamares-Orbis P, Bernal-Monterde V, Sierra-Gabarda O, Casas-Deza D, Garcia-Rayado G, Cortes L, Lué A. Impact of Liver and Pancreas Diseases on Nutritional Status. Nutrients 2021;13:1650. [PMID: 34068295 DOI: 10.3390/nu13051650] [Reference Citation Analysis]
51 Echeverría N, Comas V, Aldunate F, Perbolianachis P, Moreno P, Cristina J. In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet? . World J Hepatol 2021; 13(10): 1234-1268 [PMID: 34786164 DOI: 10.4254/wjh.v13.i10.1234] [Reference Citation Analysis]
52 Lleo A. Survival After Liver Transplantation for Autoimmune Hepatitis: Are We Messing With the Immune System? Liver Transpl 2020;26:861-2. [PMID: 32299153 DOI: 10.1002/lt.25782] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Zullo F, Saccone G, Donnarumma L, Marino I, Guida M, Berghella V. Pregnancy after liver transplantation: a case series and review of the literature. J Matern Fetal Neonatal Med 2021;34:3269-76. [PMID: 31635500 DOI: 10.1080/14767058.2019.1680632] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
54 Ursic-bedoya J, Donnadieu-rigole H, Faure S, Pageaux G. Alcohol use and smoking after liver transplantation; complications and prevention. Best Practice & Research Clinical Gastroenterology 2017;31:181-5. [DOI: 10.1016/j.bpg.2017.03.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
55 Lanari J, Hagness M, Sartori A, Rosso E, Gringeri E, Dueland S, Cillo U, Line PD. Liver transplantation versus liver resection for colorectal liver metastasis: a survival benefit analysis in patients stratified according to tumor burden score. Transpl Int 2021;34:1722-32. [PMID: 34448271 DOI: 10.1111/tri.13981] [Reference Citation Analysis]
56 Dogan N, Hüsing-Kabar A, Schmidt HH, Cicinnati VR, Beckebaum S, Kabar I. Acute allograft rejection in liver transplant recipients: Incidence, risk factors, treatment success, and impact on graft failure. J Int Med Res 2018;46:3979-90. [PMID: 29996675 DOI: 10.1177/0300060518785543] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
57 Etheredge HR, Fabian J, Duncan M, Conradie F, Tiemessen C, Botha J. Needs must: living donor liver transplantation from an HIV-positive mother to her HIV-negative child in Johannesburg, South Africa. J Med Ethics 2019;45:287-90. [PMID: 31085631 DOI: 10.1136/medethics-2018-105216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Ferrarese A, Vitale A, Sgarabotto D, Russo FP, Germani G, Gambato M, Cattelan AM, Angeli P, Cillo U, Burra P, Senzolo M. Outcome of a First Episode of Bacterial Infection in Candidates for Liver Transplantation. Liver Transpl. 2019;25:1187-1197. [PMID: 31021050 DOI: 10.1002/lt.25479] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
59 Kim JE, Sinn DH, Choi GS, Kim JM, Joh JW, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Predictors and outcome of emergent Liver transplantation for patients with acute-on-chronic liver failure. Dig Liver Dis 2021;53:1004-10. [PMID: 33931340 DOI: 10.1016/j.dld.2021.03.030] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Mitra S, De A, Chowdhury A. Epidemiology of non-alcoholic and alcoholic fatty liver diseases.Transl Gastroenterol Hepatol. 2020;5:16. [PMID: 32258520 DOI: 10.21037/tgh.2019.09.08] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 30.5] [Reference Citation Analysis]
61 Wei L, Zhang HM, Wan CD, Qu W, Zeng ZG, Liu Y, Xiong J, Sun LY, Zhu ZJ. Auxiliary Liver Graft Can Be Protected From HBV Infection in HBsAg Positive Blood Circulation. Front Med (Lausanne) 2021;8:726502. [PMID: 34513885 DOI: 10.3389/fmed.2021.726502] [Reference Citation Analysis]
62 Lin SH, Wu KT, Wang CC, Huang KT, Chen KD, Lin CC, Hsu LW, Chiu KW. HCV RNA in serum and liver samples of patients undergoing living donor liver transplantation. J Int Med Res 2021;49:3000605211034945. [PMID: 34344219 DOI: 10.1177/03000605211034945] [Reference Citation Analysis]
63 Tiwari N, Margapuri J, Katamreddy A, Jubbal S, Madan N. Diagnostic accuracy of cardiac testing for coronary artery disease in potential liver transplant recipients: A systematic review and meta-analysis. Int J Cardiol Heart Vasc 2021;32:100714. [PMID: 33521238 DOI: 10.1016/j.ijcha.2021.100714] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 De Gasperi A, Spagnolin G, Ornaghi M, Petrò L, Biancofiore G. Preoperative cardiac assessment in liver transplant candidates. Best Pract Res Clin Anaesthesiol 2020;34:51-68. [PMID: 32334787 DOI: 10.1016/j.bpa.2020.02.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
65 Herzer K, Sterneck M, Welker MW, Nadalin S, Kirchner G, Braun F, Malessa C, Herber A, Pratschke J, Weiss KH, Jaeckel E, Tacke F. Current Challenges in the Post-Transplant Care of Liver Transplant Recipients in Germany. J Clin Med 2020;9:E3570. [PMID: 33167567 DOI: 10.3390/jcm9113570] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Isayama H, Tazuma S, Kokudo N, Tanaka A, Tsuyuguchi T, Nakazawa T, Notohara K, Mizuno S, Akamatsu N, Serikawa M, Naitoh I, Hirooka Y, Wakai T, Itoi T, Ebata T, Okaniwa S, Kamisawa T, Kawashima H, Kanno A, Kubota K, Tabata M, Unno M, Takikawa H; PSC guideline committee Members: Ministry of Health, Labour and Welfare (Japan) Research Project, The Intractable Hepatobiliary Disease Study Group. Clinical guidelines for primary sclerosing cholangitis 2017. J Gastroenterol. 2018;53:1006-1034. [PMID: 29951926 DOI: 10.1007/s00535-018-1484-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
67 Sakr MA, Ebada HE, Abdelkader S, Dabbous HM, Montasser IF, Bassuny AN, Massoud YM, Abdelmoaty AS. Outcome of Colonoscopic Screening in Potential Liver Transplant Candidates. Transplant Proc 2020;52:227-32. [PMID: 32000940 DOI: 10.1016/j.transproceed.2019.10.026] [Reference Citation Analysis]
68 Kornerup LS, Pflugrad H, Weissenborn K, Vilstrup H, Dam G. Cognitive impairment after liver transplantation: residual hepatic encephalopathy or posttransplant encephalopathy? Hepat Med 2019;11:41-6. [PMID: 31040728 DOI: 10.2147/HMER.S144667] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
69 Angelico R, Sensi B, Manzia TM, Tisone G, Grassi G, Signorello A, Milana M, Lenci I, Baiocchi L. Chronic rejection after liver transplantation: Opening the Pandora’s box. World J Gastroenterol 2021; 27(45): 7771-7783 [PMID: 34963740 DOI: 10.3748/wjg.v27.i45.7771] [Reference Citation Analysis]
70 Ferrarese A, Germani G, Lazzaro S, Cananzi M, Russo FP, Senzolo M, Gambato M, Zanetto A, Cillo U, Gringeri E, Perilongo G, Burra P. Short-term outcomes of paediatric liver transplant recipients after transition to Adult Healthcare Service. Liver Int 2018;38:1316-21. [PMID: 29205755 DOI: 10.1111/liv.13655] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
71 Samuel D, Coilly A. Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation. BMC Med 2018;16:113. [PMID: 30064414 DOI: 10.1186/s12916-018-1110-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
72 Xu X, Chen J, Wei Q, Liu Z, Yang Z, Zhang M, Wang G, Gao J, Yang Z, Guo W, Xing T, Shao Z, Xie Q, Zheng S. Clinical practice guidelines on liver transplantation for hepatocellular carcinoma in China (2018 edition). Hepatobiliary & Pancreatic Diseases International 2019;18:307-12. [DOI: 10.1016/j.hbpd.2019.06.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
73 Gitto S, Aspite S, Golfieri L, Caputo F, Vizzutti F, Grandi S, Patussi V, Marra F. Alcohol use disorder and liver transplant: new perspectives and critical issues. Korean J Intern Med 2020;35:797-810. [PMID: 32241080 DOI: 10.3904/kjim.2019.409] [Reference Citation Analysis]
74 Wang R, Wang W, Ma K, Duan X, Wang F, Huang M, Zhang W, Liang T. Variation in Tacrolimus Trough Concentrations in Liver Transplant Patients Undergoing Endoscopic Retrograde Cholangiopancreatography: A Retrospective, Observational Study. Front Pharmacol 2020;11:1252. [PMID: 32973503 DOI: 10.3389/fphar.2020.01252] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
75 Mikolasevic I, Stojsavljevic S, Blazic F, Mijic M, Radic-Kristo D, Juric T, Skenderevic N, Klapan M, Lukic A, Filipec Kanizaj T. Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand? World J Transplant 2021; 11(3): 37-53 [PMID: 33816145 DOI: 10.5500/wjt.v11.i3.37] [Reference Citation Analysis]
76 Daswani R, Kumar A, Sharma P, Singla V, Bansal N, Arora A. Role of liver transplantation in severe alcoholic hepatitis. Clin Mol Hepatol 2018;24:43-50. [PMID: 29316778 DOI: 10.3350/cmh.2017.0027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
77 Gmitterová K, Minár M, Žigrai M, Košutzká Z, Kušnírová A, Valkovič P. Tacrolimus-induced parkinsonism in a patient after liver transplantation - case report. BMC Neurol 2018;18:44. [PMID: 29678162 DOI: 10.1186/s12883-018-1052-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
78 Cocero N, Frascolino C, Berta GN, Carossa S. Is It Safe to Remove Teeth in Liver Transplant Patients Without Antibiotics? A Retrospective Study of 346 Patients. J Oral Maxillofac Surg 2019;77:1557-65. [PMID: 31026420 DOI: 10.1016/j.joms.2019.03.028] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
79 European Association for the Study of the Liver. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. J Hepatol. 2018;69:154-181. [PMID: 29628280 DOI: 10.1016/j.jhep.2018.03.018] [Cited by in Crossref: 210] [Cited by in F6Publishing: 169] [Article Influence: 52.5] [Reference Citation Analysis]
80 Rao W, Liu FG, Jiang YP, Xie M. De novo multiple primary carcinomas in a patient after liver transplantation: A case report. World J Clin Cases 2021; 9(15): 3765-3772 [PMID: 34046481 DOI: 10.12998/wjcc.v9.i15.3765] [Reference Citation Analysis]
81 Genda T, Ichida T, Sakisaka S, Tanaka E, Mochida S, Ueno Y, Inui A, Egawa H, Umeshita K, Furukawa H, Kawasaki S, Inomata Y. Outcome of patients with acute liver failure awaiting liver transplantation in Japan. Hepatol Res 2020;50:1186-95. [PMID: 32720378 DOI: 10.1111/hepr.13549] [Reference Citation Analysis]
82 Verhelst X, Geerts A, Jochmans I, Vanderschaeghe D, Paradissis A, Vanlander A, Berrevoet F, Dahlqvist G, Nevens F, Pirenne J, Rogiers X, Callewaert N, Troisi RI, Van Vlierberghe H. Glycome Patterns of Perfusate in Livers Before Transplantation Associate With Primary Nonfunction. Gastroenterology 2018;154:1361-8. [DOI: 10.1053/j.gastro.2017.12.027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
83 Ferrarese A, Germani G, Gambato M, Russo FP, Senzolo M, Zanetto A, Shalaby S, Cillo U, Zanus G, Angeli P, Burra P. Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study. World J Gastroenterol 2018; 24(38): 4403-4411 [PMID: 30344424 DOI: 10.3748/wjg.v24.i38.4403] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
84 Wu Y, Wang S, Elsarawy AM, Chan Y, Chen C, Cheng B, Li L, Chiu C, Lee Y, Lin Y, Wee S, Pan C, Kao Y, Chen Y, Lin H, Lin L, Lin C. Prediction of the Development of Persistent Massive Ascites After Living Donor Liver Transplantation Using a Perioperative Risk Score. Transplantation 2018;102:e275-81. [DOI: 10.1097/tp.0000000000002174] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
85 Bielen R, Robaeys G, Schelfhout S, Monbaliu D, Van der Merwe S, Pirenne J, Nevens F. Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogs for patients at risk of renal failure after liver transplantation: a prospective single center cohort study. Transpl Int 2018;31:503-9. [PMID: 29359868 DOI: 10.1111/tri.13112] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
86 Prokopič M, Beuers U. Management of primary sclerosing cholangitis and its complications: an algorithmic approach. Hepatol Int 2021;15:6-20. [PMID: 33377990 DOI: 10.1007/s12072-020-10118-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 Hartwig V, Dewidar B, Lin T, Dropmann A, Ganss C, Kluth MA, Tappenbeck N, Tietze L, Christ B, Frank M, Vogelmann R, Ebert MPA, Dooley S. Human skin-derived ABCB5+ stem cell injection improves liver disease parameters in Mdr2KO mice. Arch Toxicol 2019;93:2645-60. [DOI: 10.1007/s00204-019-02533-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
88 Gómez Gavara C, Esposito F, Gurusamy K, Salloum C, Lahat E, Feray C, Lim C, Azoulay D. Liver transplantation in elderly patients: a systematic review and first meta-analysis. HPB 2019;21:14-25. [DOI: 10.1016/j.hpb.2018.07.025] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
89 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67:145-172. [PMID: 28427765 DOI: 10.1016/j.jhep.2017.03.022] [Cited by in Crossref: 409] [Cited by in F6Publishing: 326] [Article Influence: 81.8] [Reference Citation Analysis]
90 Zanetto A, Senzolo M, Blasi A. Perioperative management of antithrombotic treatment. Best Pract Res Clin Anaesthesiol 2020;34:35-50. [PMID: 32334786 DOI: 10.1016/j.bpa.2020.01.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
91 Salcedo M, Vinaixa C, Javle M, Trapero-Marugán M, Bustamante J, Line PD. Evaluation and Management of Liver Transplant Candidates With Prior Nonhepatic Cancer: Guidelines From the ILTS/SETH Consensus Conference. Transplantation 2022;106:e3-e11. [PMID: 34905758 DOI: 10.1097/TP.0000000000003997] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Rodríguez-Aguilar EF, Sastre L, Colmenero J, García-Valdecasas JC, Fondevila C, García Juárez I, Navasa M. Liver and kidney transplantation in polycystic liver and kidney disease. Gastroenterol Hepatol 2021:S0210-5705(21)00016-9. [PMID: 33548353 DOI: 10.1016/j.gastrohep.2020.12.004] [Reference Citation Analysis]
93 Aehling NF, Seehofer D, Berg T. [Liver transplantation - current trends]. Dtsch Med Wochenschr 2020;145:1124-31. [PMID: 32791547 DOI: 10.1055/a-0982-0737] [Reference Citation Analysis]
94 Gitto S, Falcini M, Marra F; MEDITRA Research Group. Metabolic Disorders After Liver Transplantation. Metab Syndr Relat Disord 2021;19:65-9. [PMID: 33104408 DOI: 10.1089/met.2020.0068] [Reference Citation Analysis]
95 Manzia TM, Toti L, Quaranta C, Blasi F, Tisone G. Liver transplantation with a normothermic machine preserved fatty nonagenarian liver: A case report. Int J Surg Case Rep 2019;57:163-6. [PMID: 30959367 DOI: 10.1016/j.ijscr.2019.03.033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
96 Sivaprasadan S, Mathew JS, Surendran S, Padma UD. Pregnancy After Liver Transplantation: Outcomes From a Single-Center Experience. J Clin Exp Hepatol 2020;10:329-33. [PMID: 32655236 DOI: 10.1016/j.jceh.2019.10.002] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
97 Park JS, Gayam V, Pan CQ. Review article: preventing hepatitis B graft infection in hepatitis B patients after liver transplantation: immunoglobulin vs anti-virals. Aliment Pharmacol Ther. 2020;52:944-954. [PMID: 32743822 DOI: 10.1111/apt.15999] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
98 Fernández I, Pascasio JM, Colmenero J; en nombre del grupo de trabajo para el VII consenso de la SETH., Autores participantes en el grupo de trabajo en representación de sus respectivos programas de trasplante hepático. Prophylaxis and treatment in liver transplantation. VII Consensus Document of the Spanish Society of Liver Transplantation. Gastroenterol Hepatol 2020;43:169-77. [PMID: 32094045 DOI: 10.1016/j.gastrohep.2019.11.005] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
99 Kim HY, Kim W, Jung YJ, Lee JH, Yu SJ, Kim YJ, Yoon JH, Lee HW, Kim H, Yi NJ, Lee KW, Suh KS. A Model for Adaptive Decision Making of "Ablate-and-Wait" Versus Transplantation in Patients With Hepatocellular Carcinoma. J Clin Gastroenterol 2018;52:655-61. [PMID: 29356782 DOI: 10.1097/MCG.0000000000000981] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
100 Ronca V, Podda GM, Cattaneo M. An "unmodifiable" risk factor that has been modified. Intern Emerg Med 2021;16:157-9. [PMID: 31396923 DOI: 10.1007/s11739-019-02170-9] [Reference Citation Analysis]
101 Wang J, Liu Y, Ding H, Shi X, Ren H. Mesenchymal stem cell-secreted prostaglandin E2 ameliorates acute liver failure via attenuation of cell death and regulation of macrophage polarization. Stem Cell Res Ther 2021;12:15. [PMID: 33413632 DOI: 10.1186/s13287-020-02070-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
102 Best LM, Freeman S, Sutton AJ, Hawkins N, Tsochatzis E, Gurusamy KS; Cochrane Hepato-Biliary Group. Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd013103] [Cited by in Crossref: 19] [Cited by in F6Publishing: 1] [Article Influence: 4.8] [Reference Citation Analysis]
103 Burra P, Shalaby S, Zanetto A. Long-term care of transplant recipients: De novo neoplasms after liver transplantation. Curr Opin Organ Transplant. 2018;23:187-195. [PMID: 29324517 DOI: 10.1097/mot.0000000000000499] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 4.3] [Reference Citation Analysis]
104 Rodríguez-Perálvarez M, Gómez-Bravo MÁ, Sánchez-Antolín G, De la Rosa G, Bilbao I, Colmenero J; Spanish Society of Liver Transplantation (SETH) Consensus Panel. Expanding Indications of Liver Transplantation in Spain: Consensus Statement and Recommendations by the Spanish Society of Liver Transplantation. Transplantation 2021;105:602-7. [PMID: 32345868 DOI: 10.1097/TP.0000000000003281] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 9.0] [Reference Citation Analysis]
105 Avitzur Y, Miserachs M. Quality of life on long-term parenteral nutrition: can it be an indication for intestinal transplantation? Current Opinion in Organ Transplantation 2018;23:199-206. [DOI: 10.1097/mot.0000000000000503] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
106 Michelotto J, Gassner JMGV, Moosburner S, Muth V, Patel MS, Selzner M, Pratschke J, Sauer IM, Raschzok N. Ex vivo machine perfusion: current applications and future directions in liver transplantation. Langenbecks Arch Surg 2021;406:39-54. [PMID: 33216216 DOI: 10.1007/s00423-020-02014-7] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
107 Gitto S, De Maria N, Marzi L, Magistri P, Falcini M, Vitale G, Olivieri T, Guerrini GP, Serra V, Forte P, Carrai P, De Simone P, Mega A, Zoller H, Piai G, Schepis F, Marocchi M, Villa E, Marra F, Andreone P, Di Benedetto F; other members of MEDITRA research group. Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up study. Eur J Intern Med 2020;79:70-5. [PMID: 32616342 DOI: 10.1016/j.ejim.2020.05.041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
108 Standing H, Jarvis H, Orr J, Exley C, Hudson M, Kaner E, Hanratty B. How can primary care enhance end-of-life care for liver disease? Qualitative study of general practitioners' perceptions and experiences. BMJ Open 2017;7:e017106. [PMID: 28864486 DOI: 10.1136/bmjopen-2017-017106] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
109 Belli LS, Duvoux C, Berenguer M, Berg T, Coilly A, Colle I, Fagiuoli S, Khoo S, Pageaux GP, Puoti M, Samuel D, Strazzabosco M. ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients. J Hepatol. 2017;67:585-602. [PMID: 28323126 DOI: 10.1016/j.jhep.2017.03.006] [Cited by in Crossref: 57] [Cited by in F6Publishing: 38] [Article Influence: 11.4] [Reference Citation Analysis]
110 Lué A, Martinez E, Navarro M, Laredo V, Lorente S, Jose Araiz J, Agustin Garcia-gil F, Serrano MT. Donor Age Predicts Calcineurin Inhibitor Induced Neurotoxicity After Liver Transplantation. Transplantation 2019;103:e211-5. [DOI: 10.1097/tp.0000000000002750] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
111 Koch A, Trautwein C, Tacke F. [Acute liver failure]. Med Klin Intensivmed Notfmed 2017;112:371-81. [PMID: 28444411 DOI: 10.1007/s00063-017-0282-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
112 Garbuzenko DV, Arefyev NO. Current approaches to the management of patients with cirrhotic ascites. World J Gastroenterol 2019; 25(28): 3738-3752 [PMID: 31391769 DOI: 10.3748/wjg.v25.i28.3738] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
113 Tsochatzis E, Coilly A, Nadalin S, Levistky J, Tokat Y, Ghobrial M, Klinck J, Berenguer M. International Liver Transplantation Consensus Statement on End-stage Liver Disease Due to Nonalcoholic Steatohepatitis and Liver Transplantation. Transplantation. 2019;103:45-56. [PMID: 30153225 DOI: 10.1097/tp.0000000000002433] [Cited by in Crossref: 31] [Cited by in F6Publishing: 12] [Article Influence: 10.3] [Reference Citation Analysis]
114 Silva Cruz C, Tosatto V, Nascimento PO, Barata Moura R. Hepatic hydrothorax: indwelling catheter-related Acinetobacter radioresistens infection. BMJ Case Rep 2019;12:e227635. [PMID: 30878955 DOI: 10.1136/bcr-2018-227635] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
115 Meischl T, Rasoul-Rockenschaub S, Győri G, Scheiner B, Trauner M, Soliman T, Berlakovich G, Pinter M. Alpha-fetoprotein-adjusted-to-HCC-size criteria are associated with favourable survival after liver transplantation for hepatocellular carcinoma. United European Gastroenterol J 2021;9:209-19. [PMID: 32741316 DOI: 10.1177/2050640620948665] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
116 Kalisvaart M, Schlegel A, Trivedi PJ, Roberts K, Mirza DF, Perera T, Isaac JI, Ferguson J, de Jonge J, Muiesan P. Chronic Kidney Disease After Liver Transplantation: Impact of Extended Criteria Grafts. Liver Transpl. 2019;25:922-933. [PMID: 30947384 DOI: 10.1002/lt.25468] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
117 Simonetti RG, Perricone G, Nikolova D, Bjelakovic G, Gluud C. Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis. Cochrane Database Syst Rev 2019;6:CD004039. [PMID: 31251387 DOI: 10.1002/14651858.CD004039.pub2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
118 Gitto S, de Maria N, di Benedetto F, Tarantino G, Serra V, Maroni L, Cescon M, Pinna AD, Schepis F, Andreone P, Villa E. De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients. Eur J Gastroenterol Hepatol. 2018;30:766-773. [PMID: 29505475 DOI: 10.1097/meg.0000000000001105] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
119 Koc ÖM, Kuypers D, Dupont LJ, Vos R, Van Keer JM, Van Cleemput J, Robaeys G, Oude Lashof A, Kramer M, Verleden G, Verbeek J, Nevens F. The effect of universal infant vaccination on the prevalence of hepatitis B immunity in adult solid organ transplant candidates. J Viral Hepat 2021;28:105-11. [PMID: 32989861 DOI: 10.1111/jvh.13414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
120 El-Hamamsy M, Montasser IF, Mansy AE, Nabet DE, El-Meteini M. Effect of cyclosporine A vs tacrolimus on the response to antiviral therapy after hepatitis C genotype-4 recurrence post-liver transplantation: A prospective cohort trial. J Clin Pharm Ther. 2019;44:447-453. [PMID: 30714175 DOI: 10.1111/jcpt.12807] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
121 Cristin DJ, Forman LM, Jackson WE. Beyond Survival: Targeting Health-Related Quality of Life Outcomes After Liver Transplantation. Clin Liver Dis (Hoboken) 2021;17:359-64. [PMID: 34136142 DOI: 10.1002/cld.1059] [Reference Citation Analysis]
122 Frankova S, Lunova M, Gottfriedova H, Senkerikova R, Neroldova M, Kovac J, Kieslichova E, Lanska V, Urbanek P, Spicak J, Jirsa M, Sperl J. Liver stiffness measured by two-dimensional shear-wave elastography predicts hepatic vein pressure gradient at high values in liver transplant candidates with advanced liver cirrhosis. PLoS One 2021;16:e0244934. [PMID: 33411729 DOI: 10.1371/journal.pone.0244934] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
123 Cai X, Song H, Jiao Z, Yang H, Zhu M, Wang C, Wei D, Shi L, Wu B, Chen J. Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese lung transplant recipients. Eur J Pharm Sci 2020;152:105448. [PMID: 32621968 DOI: 10.1016/j.ejps.2020.105448] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
124 Toniutto P, Zanetto A, Ferrarese A, Burra P. Current challenges and future directions for liver transplantation. Liver Int. 2017;37:317-327. [PMID: 27634369 DOI: 10.1111/liv.13255] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 6.7] [Reference Citation Analysis]
125 Jadhav PV, Kothakota SR, Sasidharan M, Kareem H, Nair AK. Effect of Donor Hepatic Steatosis on Ischemia Reperfusion Injury in Liver Transplant Recipient. J Clin Exp Hepatol 2020;10:236-44. [PMID: 32405180 DOI: 10.1016/j.jceh.2019.07.004] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
126 Sanchez-Torrijos Y, Ampuero J, Romero-Gómez M. Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do. World J Hepatol 2017; 9(15): 697-703 [PMID: 28596817 DOI: 10.4254/wjh.v9.i15.697] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
127 Addeo P, Naegel B, Terrone A, Faitot F, Schaaf C, Bachellier P, Noblet V. Analysis of factors associated with discrepancies between predicted and observed liver weight in liver transplantation. Liver Int 2021;41:1379-88. [PMID: 33555130 DOI: 10.1111/liv.14819] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
128 Piai G, Battarra V, Miglioresi L, Nacca M, Valente G. How to Improve Compliance With Dermatologic Screening in Liver Transplant Recipients: Experience in a (Spoke) Peripheral Center for Follow-up. Transplantation Proceedings 2019;51:184-6. [DOI: 10.1016/j.transproceed.2018.02.215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
129 Ye Q, Ling S, Jiang G, Shan Q, Xu S, Zhan Q, Wu Y, Liu Y, Zheng S, Xu X. Sirolimus-based immunosuppression improves the prognosis of liver Transplantation Recipients with low TSC1/2 expression in hepatocellular carcinoma beyond the Milan Criteria. Eur J Surg Oncol 2021:S0748-7983(21)00407-8. [PMID: 33902956 DOI: 10.1016/j.ejso.2021.04.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
130 Beltzer C, Quante M, Rheinberger M, Baba HA, Saner F, Fend F, Biet T, Königsrainer A, Nadalin S. [Percutaneous liver biopsy before organ removal-Impact on organ allocation and costs in liver transplantation]. Chirurg 2021;92:49-61. [PMID: 32430545 DOI: 10.1007/s00104-020-01192-w] [Reference Citation Analysis]
131 Dimitroglou Y, Aggeli C, Alexopoulou A, Mavrogeni S, Tousoulis D. Cardiac Imaging in Liver Transplantation Candidates: Current Knowledge and Future Perspectives. J Clin Med 2019;8:E2132. [PMID: 31817014 DOI: 10.3390/jcm8122132] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
132 Fatourou EM, Tsochatzis EA. Management of metabolic syndrome and cardiovascular risk after liver transplantation. Lancet Gastroenterol Hepatol. 2019;4:731-741. [PMID: 31387736 DOI: 10.1016/s2468-1253(19)30181-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
133 Ursic-bedoya J, Donnadieu-rigole H, Faure S, Pageaux G. The Influence of Alcohol Use on Outcomes in Patients Transplanted for Non-alcoholic Liver Disease. Alcohol and Alcoholism 2018;53:184-6. [DOI: 10.1093/alcalc/agx096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
134 Chagas AL, Mattos AA, Diniz MA, Felga GEG, Boin IFSF, Silva RCMA, Silva RF, Garcia JHP, Lima AS, Coelho JCU, Bittencourt PL, Alves VAF, D'Albuquerque LAC, Carrilho FJ; Brazilian HCC Study Group. Impact of Brazilian expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a multicenter study. Ann Hepatol 2021;22:100294. [PMID: 33276136 DOI: 10.1016/j.aohep.2020.100294] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
135 Kholodenko IV, Kholodenko RV, Lupatov AY, Yarygin KN. Cell Therapy as a Tool for Induction of Immunological Tolerance after Liver Transplantation. Bull Exp Biol Med 2018;165:554-63. [PMID: 30121913 DOI: 10.1007/s10517-018-4213-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
136 Zou ZY, Fan JG. Percutaneous liver biopsy: another option of hepatic sample collection approach in single-cell sequencing studies? Ann Transl Med 2020;8:1033. [PMID: 32953833 DOI: 10.21037/atm.2020.04.23] [Reference Citation Analysis]
137 Costa ARG, Freitas I, Raposo J, Barbosa G, Miranda HP, Nery F. Budd-Chiari Syndrome and Acute Liver Failure: An Uncommon Presentation of Acute Myeloid Leukaemia. GE Port J Gastroenterol 2020;28:62-6. [PMID: 33564706 DOI: 10.1159/000507335] [Reference Citation Analysis]
138 Shalaby S, Burra P. De novo and recurrent malignancy. Best Pract Res Clin Gastroenterol 2020;46-47:101680. [PMID: 33158464 DOI: 10.1016/j.bpg.2020.101680] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
139 Tacke F, Kroy DC, Barreiros AP, Neumann UP. Liver transplantation in Germany. Liver Transpl. 2016;22:1136-1142. [PMID: 27082951 DOI: 10.1002/lt.24461] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 10.2] [Reference Citation Analysis]
140 Brandman D. Obesity Management of Liver Transplant Waitlist Candidates and Recipients. Clin Liver Dis 2021;25:1-18. [PMID: 33978572 DOI: 10.1016/j.cld.2020.08.001] [Reference Citation Analysis]
141 O'neill S, Napetti S, Cornateanu S, Sutherland AI, Wigmore S, Oniscu GC, Adair A. Impact of body mass index in liver transplantation for nonalcoholic fatty liver disease and alcoholic liver disease. HPB 2017;19:1074-81. [DOI: 10.1016/j.hpb.2017.08.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
142 Ancona G, Alagna L, Lombardi A, Palomba E, Castelli V, Renisi G, Dondossola D, Iavarone M, Muscatello A, Gori A, Bandera A. The Interplay between Gut Microbiota and the Immune System in Liver Transplant Recipients and Its Role in Infections. Infect Immun 2021;89:e0037621. [PMID: 34460287 DOI: 10.1128/IAI.00376-21] [Reference Citation Analysis]
143 Heinemann ML, Elsing L, Kaiser T, Boettcher M, Herber A, Seehofer D, Berg T, Ceglarek U. Challenges of LC-MS/MS ethyl glucuronide analysis in abstinence monitoring of liver transplant candidates. Clin Chem Lab Med 2020;58:1265-70. [PMID: 32112697 DOI: 10.1515/cclm-2019-1302] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
144 Kalisvaart M, Muiesan P, Schlegel A. The UK-DCD-Risk-Score - practical and new guidance for allocation of a specific organ to a recipient? Expert Rev Gastroenterol Hepatol 2019;13:771-83. [PMID: 31173513 DOI: 10.1080/17474124.2019.1629286] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
145 Gitto S, Andreone P. Targeted pharmacotherapy for cardiovascular risk reduction in patients with diabetes undergoing liver transplantation: Author's reply. Eur J Intern Med 2020;80:105. [PMID: 32768161 DOI: 10.1016/j.ejim.2020.08.003] [Reference Citation Analysis]
146 Rodríguez-Aguilar EF, Pérez-Escobar J, Sánchez Herrera D, García-Alanis M, Toapanta-Yanchapaxi L, Gonzalez-Flores E, García-Juárez I. Bone Disease and Liver Transplantation: A Review. Transplant Proc 2021;53:2346-53. [PMID: 34420781 DOI: 10.1016/j.transproceed.2021.07.049] [Reference Citation Analysis]
147 Hagström H. Alcohol, smoking and the liver disease patient. Best Practice & Research Clinical Gastroenterology 2017;31:537-43. [DOI: 10.1016/j.bpg.2017.09.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
148 Marson EJ, Kamarajah SK, Dyson JK, White SA. Pregnancy outcomes in women with liver transplants: systematic review and meta-analysis. HPB (Oxford). 2020;22:1102-1111. [PMID: 32636057 DOI: 10.1016/j.hpb.2020.05.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
149 Schult A, Stokkeland K, Ericzon BG, Hultcrantz R, Franck J, Stål P, Castedal M. Alcohol and drug use prior to liver transplantation: more common than expected in patients with non-alcoholic liver disease. Scand J Gastroenterol 2019;54:1146-54. [PMID: 31453745 DOI: 10.1080/00365521.2019.1656772] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
150 Westin J, Aleman S, Castedal M, Duberg A, Eilard A, Fischler B, Kampmann C, Lindahl K, Lindh M, Norkrans G, Stenmark S, Weiland O, Wejstål R. Management of hepatitis B virus infection, updated Swedish guidelines. Infectious Diseases 2020;52:1-22. [DOI: 10.1080/23744235.2019.1675903] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
151 Loggi E, Conti F, Cucchetti A, Ercolani G, Pinna AD, Andreone P. Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature. World J Gastroenterol 2016; 22(35): 8010-8016 [PMID: 27672295 DOI: 10.3748/wjg.v22.i35.8010] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
152 Gallegos-orozco JF, Charlton MR. Predictors of Cardiovascular Events After Liver Transplantation. Clinics in Liver Disease 2017;21:367-79. [DOI: 10.1016/j.cld.2016.12.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
153 Burra P, Becchetti C, Germani G. NAFLD and liver transplantation: Disease burden, current management and future challenges. JHEP Rep 2020;2:100192. [PMID: 33163950 DOI: 10.1016/j.jhepr.2020.100192] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
154 Lué A, Solanas E, Baptista P, Lorente S, Araiz JJ, Garcia-Gil A, Serrano MT. How important is donor age in liver transplantation? World J Gastroenterol 2016; 22(21): 4966-4976 [PMID: 27275089 DOI: 10.3748/wjg.v22.i21.4966] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 38] [Article Influence: 7.5] [Reference Citation Analysis]
155 Smilowitz NR, Guo Y, Rao S, Gelb B, Berger JS, Bangalore S. Perioperative cardiovascular outcomes of non-cardiac solid organ transplant surgery. Eur Heart J Qual Care Clin Outcomes 2019;5:72-8. [PMID: 29961872 DOI: 10.1093/ehjqcco/qcy028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
156 Weiss N, Thabut D. Neurological Complications Occurring After Liver Transplantation: Role of Risk Factors, Hepatic Encephalopathy, and Acute (on Chronic) Brain Injury. Liver Transpl. 2019;25:469-487. [PMID: 30697911 DOI: 10.1002/lt.25420] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
157 Sedano R, Castro L, Venegas M, Miranda J, Hurtado C, Poniachik J, Brahm J. Liver transplantation in acute liver failure due to Hepatitis B. Two clinical cases. Ann Hepatol 2021;21:100107. [PMID: 31623992 DOI: 10.1016/j.aohep.2019.06.012] [Reference Citation Analysis]
158 Zhang Y, Huang C, Nie Y, Liu Q, Xiao N, Liu L, Zhu X. Soluble CD163 Is a Predictor of Mortality in Patients With Decompensated Cirrhosis. Front Med (Lausanne) 2021;8:698502. [PMID: 34336902 DOI: 10.3389/fmed.2021.698502] [Reference Citation Analysis]
159 Ho CM, Lee PH, Cheng WT, Hu RH, Wu YM, Ho MC. Succinct guide to liver transplantation for medical students. Ann Med Surg (Lond) 2016;12:47-53. [PMID: 27895907 DOI: 10.1016/j.amsu.2016.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
160 Choi D, Thaker S, West-Thielke P, Elmasri A, Chan C. Evaluating the conversion to extended-release tacrolimus from immediate-release tacrolimus in liver transplant recipients. Eur J Gastroenterol Hepatol 2021;33:1124-8. [PMID: 34213506 DOI: 10.1097/MEG.0000000000002172] [Reference Citation Analysis]
161 Arora A, Singh SP, Kumar A, Saraswat VA, Aggarwal R, Bangar M, Bhaumik P, Devarbhavi H, Dhiman RK, Dixit VK, Goel A, Goswami B, Kapoor D, Madan K, Narayan J, Nijhawan S, Pandey G, Rai RR, Sahu MK, Saraf N, Shalimar, Shenoy T, Thomas V, Wadhawan M; INASL Hepatitis B Taskforce. INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements. J Clin Exp Hepatol 2018;8:58-80. [PMID: 29743798 DOI: 10.1016/j.jceh.2017.12.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
162 Besch C, Michard B, Addeo P, Oncioiu C, Ellero B, Woehl-Jaegle ML, Bachellier P, Faitot F. Impact of early remote organ dysfunction on long-term survival after liver transplantation. Clin Res Hepatol Gastroenterol 2019;43:730-7. [PMID: 30954392 DOI: 10.1016/j.clinre.2019.02.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
163 Kamarajah SK, Arntdz K, Bundred J, Gunson B, Haydon G, Thompson F. Outcomes of Pregnancy in Recipients of Liver Transplants. Clin Gastroenterol Hepatol 2019;17:1398-1404.e1. [PMID: 30529735 DOI: 10.1016/j.cgh.2018.11.055] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
164 Gitto S, Di Sandro S, Magistri P, Andreone P, Di Benedetto F. Hepatocellular carcinoma and liver transplant: beyond the Milan criteria and the risk of "short-blanket" syndrome. Hepatobiliary Surg Nutr 2020;9:518-21. [PMID: 32832508 DOI: 10.21037/hbsn.2019.11.34] [Reference Citation Analysis]
165 Pinter M, Trauner M, Peck-Radosavljevic M, Sieghart W. Cancer and liver cirrhosis: implications on prognosis and management. ESMO Open. 2016;1:e000042. [PMID: 27843598 DOI: 10.1136/esmoopen-2016-000042] [Cited by in Crossref: 108] [Cited by in F6Publishing: 94] [Article Influence: 18.0] [Reference Citation Analysis]
166 Orfanidou A, Papatheodoridis GV, Cholongitas E. Antiviral prophylaxis against hepatitis B recurrence after liver transplantation: Current concepts. Liver Int 2021;41:1448-61. [PMID: 33656809 DOI: 10.1111/liv.14860] [Reference Citation Analysis]
167 Carrier P, Debette-gratien M, Essig M, Loustaud-ratti V. Beyond serum creatinine: which tools to evaluate renal function in cirrhotic patients?: Beyond serum creatinine. Hepatol Res 2018;48:771-9. [DOI: 10.1111/hepr.13224] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
168 Liu ED, Nituleasa A, Amidon RF, Ordookhanian C, Kaloostian P. Hepatic Transplantation Raises Concern for Vascular Infrastructure Compromise: A Case Study of Debilitating Arteriovenous Malformation. Cureus 2021;13:e18518. [PMID: 34765326 DOI: 10.7759/cureus.18518] [Reference Citation Analysis]
169 Buganza-torio E, Doucette KE. Management of Viral Hepatitis in Solid Organ Transplant Recipients. Infectious Disease Clinics of North America 2018;32:635-50. [DOI: 10.1016/j.idc.2018.04.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
170 Jothimani D, Venugopal R, Vij M, Rela M. Post liver transplant recurrent and de novo viral infections. Best Pract Res Clin Gastroenterol. 2020;46-47:101689. [PMID: 33158469 DOI: 10.1016/j.bpg.2020.101689] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
171 Haas KP, Chen AC. Indwelling tunneled pleural catheters for the management of hepatic hydrothorax. Current Opinion in Pulmonary Medicine 2017;23:351-6. [DOI: 10.1097/mcp.0000000000000386] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
172 Morgul MH, Felgendreff P, Kienlein A, Gauger U, Semmling K, Hau HM, Tautenhahn HM, Bartels M. Milan criteria in the MELD era-is it justifiable to extend the limits for orthotopic liver transplantation?World J Surg Oncol. 2020;18:158. [PMID: 32635931 DOI: 10.1186/s12957-020-01932-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
173 Sandal S, Chen T, Cantarovich M. Evaluation of Transplant Candidates With a History of Nonadherence: An Opinion Piece. Can J Kidney Health Dis 2021;8:2054358121990137. [PMID: 33598301 DOI: 10.1177/2054358121990137] [Reference Citation Analysis]
174 Del Bello A, Congy-Jolivet N, Danjoux M, Muscari F, Lavayssière L, Esposito L, Hebral AL, Bellière J, Kamar N. High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation. World J Gastroenterol 2018; 24(16): 1795-1802 [PMID: 29713132 DOI: 10.3748/wjg.v24.i16.1795] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
175 Faitot F, Besch C, Lebas B, Addeo P, Ellero B, Woehl-jaegle M, Namer I, Bachellier P, Freys G. Interleukin 6 at reperfusion: A potent predictor of hepatic and extrahepatic early complications after liver transplantation. Clin Transplant 2018;32:e13357. [DOI: 10.1111/ctr.13357] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
176 Werner JM, Schlitt HJ. Living Donor Liver Transplantation. Transplantation 2016;100:1173-4. [DOI: 10.1097/tp.0000000000001282] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
177 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu., Clinical Practice Guideline Panel: Chair:., Panel members:., EASL Governing Board representative:. EASL Clinical Practice Guideline: Occupational liver diseases. J Hepatol 2019;71:1022-37. [PMID: 31540728 DOI: 10.1016/j.jhep.2019.08.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
178 Parry MJ, Isoniemi H, Koivusalo AM, Hoppu K. Increased acetaminophen related calls to Finnish PIC better reflect acetaminophen sales than serious poisonings. Clin Toxicol (Phila) 2018;56:209-15. [PMID: 28812385 DOI: 10.1080/15563650.2017.1359619] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
179 Jiménez-Gutiérrez JM, García-Juárez I, Olivas-Martinez A, Ruiz I. One-year outcome of patients with cirrhosis who developed spontaneous bacterial empyema: A cohort study. J Dig Dis 2021. [PMID: 34738327 DOI: 10.1111/1751-2980.13066] [Reference Citation Analysis]
180 Riedel AN, Kimer N, Hobolth L, Gluud LL. Prognosis of patients with ascites after PleurX insertion: an observational study. Scand J Gastroenterol. 2018;53:340-344. [PMID: 29411667 DOI: 10.1080/00365521.2018.1436190] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
181 Haberl J, Zollner G, Fickert P, Stadlbauer V. To salt or not to salt?-That is the question in cirrhosis. Liver Int. 2018;38:1148-1159. [PMID: 29608812 DOI: 10.1111/liv.13750] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
182 Angelico R, Parente A, Manzia TM. Using a weaning immunosuppression protocol in liver transplantation recipients with hepatocellular carcinoma: A compromise between the risk of recurrence and the risk of rejection? Transl Gastroenterol Hepatol. 2017;2:74. [PMID: 29034347 DOI: 10.21037/tgh.2017.08.07] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
183 Colombo M. EASL clinical practice guidelines for the management of occupational liver diseases. Liver Int 2020;40 Suppl 1:136-41. [PMID: 32077606 DOI: 10.1111/liv.14349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
184 Cholongitas E. Mammalian Target of Rapamycin Inhibitors Against Hepatocellular Carcinoma Recurrence After Liver Transplantation. Transplantation 2016;100:e43-4. [PMID: 27306530 DOI: 10.1097/TP.0000000000001256] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
185 Niemann CU, Biancofiore G. Transplant anesthesia and critical care: Current research and possible future developments. Best Pract Res Clin Anaesthesiol 2020;34:1-2. [PMID: 32334779 DOI: 10.1016/j.bpa.2020.03.001] [Reference Citation Analysis]
186 Shin S, Kim TS, Lee JW, Ahn KS, Kim YH, Kang KJ. Is the anatomical resection necessary for single hepatocellular carcinoma smaller than 3 cm?: single-center experience of liver resection for a small HCC. Ann Hepatobiliary Pancreat Surg 2018;22:326-34. [PMID: 30588523 DOI: 10.14701/ahbps.2018.22.4.326] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
187 Hausken J, Haugaa H, Hagness M, Line PD, Melum E, Tønnessen TI. Thoracic Epidural Analgesia for Postoperative Pain Management in Liver Transplantation: A 10-year Study on 685 Liver Transplant Recipients. Transplant Direct 2021;7:e648. [PMID: 33437863 DOI: 10.1097/TXD.0000000000001101] [Reference Citation Analysis]
188 Valente G, Miglioresi L, Sgueglia T, Rinaldi L, Piai G. Toward Zero Hepatitis C Virus-Related Mortality as a Prerequisite for the Release of Resources in a Center for Follow-up of Liver Transplant. Transplant Proc 2019;51:2958-61. [PMID: 31629537 DOI: 10.1016/j.transproceed.2019.04.093] [Reference Citation Analysis]
189 Sirrs S, Hannah-shmouni F, Nantel S, Neuberger J, Yoshida EM. Transplantation as disease modifying therapy in adults with inherited metabolic disorders. J Inherit Metab Dis 2018;41:885-96. [DOI: 10.1007/s10545-018-0141-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
190 Millson C, Considine A, Cramp ME, Holt A, Hubscher S, Hutchinson J, Jones K, Leithead J, Masson S, Menon K, Mirza D, Neuberger J, Prasad R, Pratt A, Prentice W, Shepherd L, Simpson K, Thorburn D, Westbrook R, Tripathi D. Adult liver transplantation: UK clinical guideline - part 2: surgery and post-operation. Frontline Gastroenterol 2020;11:385-96. [PMID: 32879722 DOI: 10.1136/flgastro-2019-101216] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
191 Di Dato F, Nunziata F, Rosa M, Iorio R, Spagnuolo MI. Tubercular hemoptysis in a young liver transplanted patient: Case report. Medicine (Baltimore) 2019;98:e16761. [PMID: 31415374 DOI: 10.1097/MD.0000000000016761] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
192 Martini S, Caccamo L, Rizzetto M. Are immunoglobulins against the HBsAg still needed in liver transplantation for hepatitis D? Hepatology 2018;67:2475-6. [PMID: 29356031 DOI: 10.1002/hep.29796] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
193 Hickman IJ, Hannigan AK, Johnston HE, Elvin-Walsh L, Mayr HL, Staudacher HM, Barnett A, Stoney R, Salisbury C, Jarrett M, Reeves MM, Coombes JS, Campbell KL, Keating SE, Macdonald GA. Telehealth-delivered, Cardioprotective Diet and Exercise Program for Liver Transplant Recipients: A Randomized Feasibility Study. Transplant Direct 2021;7:e667. [PMID: 33564717 DOI: 10.1097/TXD.0000000000001118] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Cacicedo ML, Medina-Montano C, Kaps L, Kappel C, Gehring S, Bros M. Role of Liver-Mediated Tolerance in Nanoparticle-Based Tumor Therapy. Cells 2020;9:E1985. [PMID: 32872352 DOI: 10.3390/cells9091985] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
195 Guiral S, Segundo DS, Irure J, Casafont F, Fortea JI, Puente Á, López-hoyos M, Crespo J, Fabrega E. Number of Antibody-verified Eplet in HLA-C Locus as an Independent Factor of T-cell–Mediated Rejection After Liver Transplantation. Transplantation 2020;104:562-7. [DOI: 10.1097/tp.0000000000002921] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
196 Kok B, Dong V, Karvellas CJ. Graft Dysfunction and Management in Liver Transplantation. Crit Care Clin 2019;35:117-33. [PMID: 30447775 DOI: 10.1016/j.ccc.2018.08.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
197 Toniutto P, Bitetto D, Fornasiere E, Fumolo E. Challenges and future developments in liver transplantation. Minerva Gastroenterol Dietol 2019;65:136-52. [PMID: 30303340 DOI: 10.23736/S1121-421X.18.02529-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
198 Manzia TM, Angelico R, Gazia C, Lenci I, Milana M, Ademoyero OT, Pedini D, Toti L, Spada M, Tisone G, Baiocchi L. De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature. World J Gastroenterol 2019; 25(35): 5356-5375 [PMID: 31558879 DOI: 10.3748/wjg.v25.i35.5356] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
199 Geissler EK, Schnitzbauer AA, Schlitt HJ; SiLVER Study Group. The Authors' Reply. Transplantation 2016;100:e44-5. [PMID: 27362305 DOI: 10.1097/TP.0000000000001255] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
200 Moctezuma-Velazquez C, Márquez-Guillén E, Torre A. Obesity in the Liver Transplant Setting. Nutrients 2019;11:E2552. [PMID: 31652761 DOI: 10.3390/nu11112552] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
201 Mikolasevic I, Filipec-Kanizaj T, Mijic M, Jakopcic I, Milic S, Hrstic I, Sobocan N, Stimac D, Burra P. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand? World J Gastroenterol 2018; 24(14): 1491-1506 [PMID: 29662288 DOI: 10.3748/wjg.v24.i14.1491] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 43] [Article Influence: 12.5] [Reference Citation Analysis]
202 Tejedor-Tejada J, Valenzuela EF, Muñoz RN, Gómez LH, García-Pajares F, Álvarez CA, Sánchez-Martín F, Alonso-Martín C, Sánchez-Antolín G. De-novo nonalcoholic fatty liver disease at 5 years after liver transplantation: prevalence and predictive factors. Eur J Gastroenterol Hepatol 2021;33:399-406. [PMID: 32317584 DOI: 10.1097/MEG.0000000000001736] [Reference Citation Analysis]
203 Mattei G, Moscara M, Balducci J, Cavana S, Cherubini M, Piemonte C, Ferrari S, Galeazzi GM. Stability of Psychiatric Diagnoses in Candidates to Liver Transplantation Referred to a Consultation-Liaison Psychiatry Service. J Clin Med 2019;8:E800. [PMID: 31195696 DOI: 10.3390/jcm8060800] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
204 Bellini MI, Fresilli D, Lauro A, Mennini G, Rossi M, Catalano C, D’andrea V, Cantisani V, Kaiser G. Liver Transplant Imaging prior to and during the COVID-19 Pandemic. BioMed Research International 2022;2022:1-9. [DOI: 10.1155/2022/7768383] [Reference Citation Analysis]
205 Halliday N, Westbrook RH. Liver transplantation: need, indications, patient selection and pre-transplant care. Br J Hosp Med (Lond) 2017;78:252-9. [PMID: 28489446 DOI: 10.12968/hmed.2017.78.5.252] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
206 Satapathy SK, Jiang Y, Agbim U, Wu C, Bernstein DE, Teperman LW, Kedia SK, Aithal GP, Bhamidimarri KR, Duseja A, Maiwall R, Maliakkal B, Jalal P, Patel K, Puri P, Ravinuthala R, Wong VW, Abdelmalek MF, Ahmed A, Thuluvath PJ, Singal AK; for the Global NAFLD Consortium. Posttransplant Outcome of Lean Compared With Obese Nonalcoholic Steatohepatitis in the United States: The Obesity Paradox. Liver Transpl 2019;26:68-79. [DOI: 10.1002/lt.25672] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
207 Lunova M, Frankova S, Gottfriedova H, Senkerikova R, Neroldova M, Kovac J, Kieslichova E, Lanska V, Sticova E, Spicak J, Jirsa M, Sperl J. Portal hypertension is the main driver of liver stiffness in advanced liver cirrhosis. Physiol Res 2021;70:563-77. [PMID: 34062072 DOI: 10.33549/physiolres.934626] [Reference Citation Analysis]
208 Zaccherini G, Tufoni M, Bernardi M, Caraceni P. Prevention of Cirrhosis Complications: Looking for Potential Disease Modifying Agents. J Clin Med 2021;10:4590. [PMID: 34640608 DOI: 10.3390/jcm10194590] [Reference Citation Analysis]
209 Martins P, Verdelho Machado M. Secondary Sclerosing Cholangitis in Critically Ill Patients: An Underdiagnosed Entity. GE Port J Gastroenterol 2020;27:103-14. [PMID: 32266307 DOI: 10.1159/000501405] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
210 Amorim J, França M, Perez-girbes A, Torregrosa A, Martí-bonmatí L. Critical review of HCC imaging in the multidisciplinary setting: treatment allocation and evaluation of response. Abdom Radiol 2020;45:3119-28. [DOI: 10.1007/s00261-020-02470-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
211 Golfieri L, Gitto S, Vukotic R, Andreone P, Marra F, Morelli MC, Cescon M, Grandi S. Impact of psychosocial status on liver transplant process. Annals of Hepatology 2019;18:804-9. [DOI: 10.1016/j.aohep.2019.06.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
212 Hagström H. Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much? Curr Hepatol Rep 2017;16:152-7. [PMID: 28706775 DOI: 10.1007/s11901-017-0343-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
213 Qi ZL, Sun LY, Bai J, Zhuang HZ, Duan ML. Japanese encephalitis following liver transplantation: A rare case report. World J Clin Cases 2020; 8(2): 337-342 [PMID: 32047783 DOI: 10.12998/wjcc.v8.i2.337] [Reference Citation Analysis]
214 Barreto SG, Brooke-Smith ME, Neo EL, Dolan P, Leibbrandt R, Emery T, Carroll R, Wigg A, Chen JW. Exploring pre-surgery donor-specific antibodies in the context of organ shortage in liver transplant. Langenbecks Arch Surg 2019;404:865-74. [PMID: 31748871 DOI: 10.1007/s00423-019-01831-9] [Reference Citation Analysis]
215 Dehne S, Lund F, Larmann J, Schmidt K, Brenner T, Weigand MA, von Haken R. [Anesthesiological aspects of liver transplantation]. Anaesthesist 2019;68:403-18. [PMID: 31049602 DOI: 10.1007/s00101-019-0595-x] [Reference Citation Analysis]
216 Pais R, Barritt AS 4th, Calmus Y, Scatton O, Runge T, Lebray P, Poynard T, Ratziu V, Conti F. NAFLD and liver transplantation: Current burden and expected challenges. J Hepatol. 2016;65:1245-1257. [PMID: 27486010 DOI: 10.1016/j.jhep.2016.07.033] [Cited by in Crossref: 190] [Cited by in F6Publishing: 172] [Article Influence: 31.7] [Reference Citation Analysis]
217 Mezochow AK, Abt PL, Bittermann T. Differences in Early Immunosuppressive Therapy Among Liver Retransplantation Recipients in a National Cohort. Transplantation 2021;105:1800-7. [PMID: 32804798 DOI: 10.1097/TP.0000000000003417] [Reference Citation Analysis]
218 De Luca L, Kalafateli M, Bianchi S, Alasaker N, Buzzetti E, Rodríguez‐perálvarez M, Thorburn D, O'beirne J, Patch D, Leandro G, Westbrook R, Tsochatzis EA. Cardiovascular morbidity and mortality is increased post‐liver transplantation even in recipients with no pre‐existing risk factors. Liver Int 2019;39:1557-65. [DOI: 10.1111/liv.14185] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
219 Mehta N, Heimbach J, Harnois DM, Sapisochin G, Dodge JL, Lee D, Burns JM, Sanchez W, Greig PD, Grant DR, Roberts JP, Yao FY. Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant. JAMA Oncol. 2017;3:493-500. [PMID: 27838698 DOI: 10.1001/jamaoncol.2016.5116] [Cited by in Crossref: 111] [Cited by in F6Publishing: 104] [Article Influence: 22.2] [Reference Citation Analysis]
220 Saliba F, Fischer L, de Simone P, Bernhardt P, Bader G, Fung J. Association Between Renal Dysfunction and Major Adverse Cardiac Events After Liver Transplantation: Evidence from an International Randomized Trial of Everolimus-Based Immunosuppression. Ann Transplant 2018;23:751-7. [PMID: 30361470 DOI: 10.12659/AOT.911030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
221 Tasdogan BE, Ma M, Simsek C, Saberi B, Gurakar A. Update on Immunosuppression in Liver Transplantation. Euroasian J Hepatogastroenterol. 2019;9:96-101. [PMID: 32117698 DOI: 10.5005/jp-journals-10018-1301] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
222 Senkerikova R, Frankova S, Jirsa M, Kreidlova M, Merta D, Neroldova M, Chmelova K, Spicak J, Sperl J. PNPLA3 rs738409 G allele carriers with genotype 1b HCV cirrhosis have lower viral load but develop liver failure at younger age. PLoS One 2019;14:e0222609. [PMID: 31527889 DOI: 10.1371/journal.pone.0222609] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
223 Estes C, Anstee QM, Arias-Loste MT, Bantel H, Bellentani S, Caballeria J, Colombo M, Craxi A, Crespo J, Day CP, Eguchi Y, Geier A, Kondili LA, Kroy DC, Lazarus JV, Loomba R, Manns MP, Marchesini G, Nakajima A, Negro F, Petta S, Ratziu V, Romero-Gomez M, Sanyal A, Schattenberg JM, Tacke F, Tanaka J, Trautwein C, Wei L, Zeuzem S, Razavi H. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. J Hepatol. 2018;69:896-904. [PMID: 29886156 DOI: 10.1016/j.jhep.2018.05.036] [Cited by in Crossref: 381] [Cited by in F6Publishing: 362] [Article Influence: 95.3] [Reference Citation Analysis]
224 Mathurin P, Lucey MR. Liver transplantation in patients with alcohol-related liver disease: current status and future directions. The Lancet Gastroenterology & Hepatology 2020;5:507-14. [DOI: 10.1016/s2468-1253(19)30451-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 7.5] [Reference Citation Analysis]
225 Maurice J, Pinzani M. The stratification of cirrhosis. Hepatol Res 2020;50:535-41. [PMID: 32072721 DOI: 10.1111/hepr.13493] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
226 Kim KM, Shim SG, Sinn DH, Song JE, Kim BS, Kim HG. Child-Pugh, MELD, MELD-Na, and ALBI scores: which liver function models best predicts prognosis for HCC patient with ascites? Scand J Gastroenterol 2020;55:951-7. [PMID: 32698637 DOI: 10.1080/00365521.2020.1788139] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
227 Suzuki Y, Kakisaka K, Suzuki A, Takahara T, Sasaki T, Sato T, Yonezawa T, Nitta H, Takikawa Y. A Lille model for predicting the response of severe alcoholic hepatitis to corticosteroid treatment in Japanese patients. Hepatol Res 2019;49:758-64. [PMID: 30901152 DOI: 10.1111/hepr.13334] [Reference Citation Analysis]
228 Jiménez‐pérez M, González‐grande R, García‐cortés M, Andrade RJ. Drug‐Induced Liver Injury After Liver Transplantation. Liver Transpl 2020;26:1167-76. [DOI: 10.1002/lt.25804] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
229 Phillips PK, Saha S, Foley DP, Iruretagoyena JI, Said A. Deficiencies in reproductive health counseling in liver transplant recipients. Clin Transplant 2019;33:e13631. [PMID: 31173406 DOI: 10.1111/ctr.13631] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
230 Hsiao CY, Ho MC, Ho CM, Wu YM, Lee PH, Hu RH. Long-Term Tacrolimus Blood Trough Level and Patient Survival in Adult Liver Transplantation. J Pers Med 2021;11:90. [PMID: 33535628 DOI: 10.3390/jpm11020090] [Reference Citation Analysis]
231 Majumdar A, Verbeek J, Tsochatzis EA. Non-alcoholic fatty liver disease: Current therapeutic options. Curr Opin Pharmacol 2021;61:98-105. [PMID: 34688168 DOI: 10.1016/j.coph.2021.09.007] [Reference Citation Analysis]
232 Tan AT, Yang N, Lee Krishnamoorthy T, Oei V, Chua A, Zhao X, Tan HS, Chia A, Le Bert N, Low D, Tan HK, Kumar R, Irani FG, Ho ZZ, Zhang Q, Guccione E, Wai LE, Koh S, Hwang W, Chow WC, Bertoletti A. Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy. Gastroenterology. 2019;156:1862-1876.e9. [PMID: 30711630 DOI: 10.1053/j.gastro.2019.01.251] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 12.3] [Reference Citation Analysis]
233 Ito T, Naini BV, Markovic D, Aziz A, Younan S, Lu M, Hirao H, Kadono K, Kojima H, DiNorcia J 3rd, Agopian VG, Yersiz H, Farmer DG, Busuttil RW, Kupiec-Weglinski JW, Kaldas FM. Ischemia-reperfusion injury and its relationship with early allograft dysfunction in liver transplant patients. Am J Transplant 2021;21:614-25. [PMID: 32713098 DOI: 10.1111/ajt.16219] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
234 Henson JB, Wilder JM, Kappus MR, Barbas AS, Moylan CA, Niedzwiecki D, Muir AJ, Berg CL, Patel YA. Transplant Outcomes in Older Patients With Nonalcoholic Steatohepatitis Compared to Alcohol-related Liver Disease and Hepatitis C. Transplantation 2020;104:e164-73. [PMID: 32150036 DOI: 10.1097/TP.0000000000003219] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
235 Schlegel A, Muller X, Dutkowski P. Machine perfusion strategies in liver transplantation. Hepatobiliary Surg Nutr 2019;8:490-501. [PMID: 31673538 DOI: 10.21037/hbsn.2019.04.04] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
236 Protopapas AA, Papagiouvanni I, Fragkou N, Alevroudis E, Sinakos E, Goulis I. Estimation of glomerular filtration rate in patients with cirrhosis: evaluation of equations currently used in clinical practice and validation of Royal Free Hospital cirrhosis glomerular filtration rate. Eur J Gastroenterol Hepatol 2022;34:84-91. [PMID: 32956187 DOI: 10.1097/MEG.0000000000001935] [Reference Citation Analysis]
237 Mrzljak A, Novak R, Pandak N, Tabain I, Franusic L, Barbic L, Bogdanic M, Savic V, Mikulic D, Pavicic-Saric J, Stevanovic V, Vilibic-Cavlek T. Emerging and neglected zoonoses in transplant population. World J Transplant 2020; 10(3): 47-63 [PMID: 32257849 DOI: 10.5500/wjt.v10.i3.47] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
238 Vilchez-Monge AL, Garutti I, Jimeno C, Zaballos M, Jimenez C, Olmedilla L, Piñeiro P, Duque P, Salcedo M, Asencio JM, Lopez-Baena JA, Maruszewski P, Bañares R, Perez-Peña JM. Intraoperative Troponin Elevation in Liver Transplantation Is Independently Associated With Mortality: A Prospective Observational Study. Liver Transpl 2020;26:681-92. [PMID: 31944566 DOI: 10.1002/lt.25716] [Reference Citation Analysis]
239 Tschuor C, Ferrarese A, Kuemmerli C, Dutkowski P, Burra P, Clavien PA;  Liver Allocation Study Group. Allocation of liver grafts worldwide - Is there a best system? J Hepatol. 2019;71:707-718. [PMID: 31199941 DOI: 10.1016/j.jhep.2019.05.025] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
240 Martini S, Tandoi F, Terzi di Bergamo L, Strona S, Lavezzo B, Sacco M, Maione F, Gonella F, Strignano P, Dell Olio D, Salizzoni M, Saracco GM, Romagnoli R. Negativization of viremia prior to liver transplant reduces early allograft dysfunction in hepatitis C-positive recipients. Liver Transpl 2017;23:915-24. [PMID: 28422425 DOI: 10.1002/lt.24772] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
241 Duvoux C, Belli LS, Fung J, Angelico M, Buti M, Coilly A, Cortesi P, Durand F, Féray C, Fondevila C, Lebray P, Martini S, Nevens F, Polak WG, Rizzetto M, Volpes R, Zoulim F, Samuel D, Berenguer M. 2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus-related infection before and after liver transplantation. Aliment Pharmacol Ther 2021;54:583-605. [PMID: 34287994 DOI: 10.1111/apt.16374] [Reference Citation Analysis]
242 Ji E, Kim MG, Oh JM. CYP3A5 genotype-based model to predict tacrolimus dosage in the early postoperative period after living donor liver transplantation. Ther Clin Risk Manag 2018;14:2119-26. [PMID: 30498355 DOI: 10.2147/TCRM.S184376] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
243 Kim SB, Chang JW, Shin JH, Cho KS, Jung DH, Song GW, Ha TY, Moon DB, Kim KH, Ahn CS, Hwang S, Lee SG. Renal Recovery After Liver Transplantation Alone in Patients With Liver Cirrhosis and Severe Chronic Kidney Disease With Normal Kidney Size. Transplant Proc 2021;53:1719-25. [PMID: 33741203 DOI: 10.1016/j.transproceed.2021.01.016] [Reference Citation Analysis]
244 Pecoraro A, Crescenzi L, Varricchi G, Marone G, Spadaro G. Heterogeneity of Liver Disease in Common Variable Immunodeficiency Disorders. Front Immunol 2020;11:338. [PMID: 32184784 DOI: 10.3389/fimmu.2020.00338] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
245 Thölking G, Gerth HU, Schuette-Nuetgen K, Reuter S. Influence of tacrolimus metabolism rate on renal function after solid organ transplantation. World J Transplant 2017; 7(1): 26-33 [PMID: 28280692 DOI: 10.5500/wjt.v7.i1.26] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
246 Choudhary NS, Saraf N, Saigal S, Soin AS. Long-term Management of the Adult Liver Transplantation Recipients. J Clin Exp Hepatol 2021;11:239-53. [PMID: 33746450 DOI: 10.1016/j.jceh.2020.06.010] [Reference Citation Analysis]
247 Choi JM, Kong YG, Kang JW, Kim YK. Coronary Computed Tomography Angiography in Combination with Coronary Artery Calcium Scoring for the Preoperative Cardiac Evaluation of Liver Transplant Recipients. Biomed Res Int 2017;2017:4081525. [PMID: 28164120 DOI: 10.1155/2017/4081525] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
248 Vasco M, Benincasa G, Fiorito C, Faenza M, De Rosa P, Maiello C, Santangelo M, Vennarecci G, Napoli C. Clinical epigenetics and acute/chronic rejection in solid organ transplantation: An update. Transplant Rev (Orlando) 2021;35:100609. [PMID: 33706201 DOI: 10.1016/j.trre.2021.100609] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
249 van den Hoogen MWF, Seghers L, Manintveld OC, Roest S, Bekkers JA, den Hoed CM, Minnee RC, de Geus HRH, van Thiel RJ, Hesselink DA. Care for the organ transplant recipient on the intensive care unit. J Crit Care 2021;64:37-44. [PMID: 33784577 DOI: 10.1016/j.jcrc.2021.03.003] [Reference Citation Analysis]
250 Addeo P, Schaaf C, Noblet V, Faitot F, Lebas B, Mahoudeau G, Besch C, Serfaty L, Bachellier P. The learning curve for piggyback liver transplantation: identifying factors challenging surgery. Surgery 2021;169:974-82. [PMID: 33143932 DOI: 10.1016/j.surg.2020.09.036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
251 Freitas M, Xavier S, Magalhães R, Magalhães J, Marinho C, Cotter J. LIRER score - a valuable tool to predict medium-long-term outcomes in hepatic cirrhosis decompensation. Scand J Gastroenterol 2020;55:1079-86. [PMID: 32715829 DOI: 10.1080/00365521.2020.1797156] [Reference Citation Analysis]
252 Pérez-Cameo C, Lung M, Hidalgo E, Gómez-Gavara C, Vargas V, Nuvials X, Los-Arcos I, Castells L, Len O. Does Routine Abdominal Drain Tip Culture Anticipate Post-Operative Infection in Liver Transplantation? Surg Infect (Larchmt) 2021;22:222-6. [PMID: 32429799 DOI: 10.1089/sur.2020.031] [Reference Citation Analysis]
253 Buscemi V, De Carlis R, Lauterio A, Camozzi ML, De Carlis L. Liver Transplantation From a Donor With Noonan Syndrome: Caveat Emptor. Transplantation 2021;105:e50-1. [PMID: 33760797 DOI: 10.1097/TP.0000000000003626] [Reference Citation Analysis]
254 Neuberger JM, Bechstein WO, Kuypers DR, Burra P, Citterio F, De Geest S, Duvoux C, Jardine AG, Kamar N, Krämer BK, Metselaar HJ, Nevens F, Pirenne J, Rodríguez-Perálvarez ML, Samuel D, Schneeberger S, Serón D, Trunečka P, Tisone G, van Gelder T. Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group. Transplantation 2017;101:S1-S56. [PMID: 28328734 DOI: 10.1097/TP.0000000000001651] [Cited by in Crossref: 114] [Cited by in F6Publishing: 43] [Article Influence: 22.8] [Reference Citation Analysis]
255 Zhang X, Ying Y, Zhou P, Liu X, Li R, Tao Y, Dong M, Zhu B, Qi X, Wang Q, Zhang X, Wu J, Zheng J, Zhao W, Zhang W, Wang Z, Zhang J, Huang Y. A Stepwise Evaluation of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure to Optimize the Indication for Urgent Liver Transplantation. Dig Dis Sci 2021;66:284-95. [PMID: 32140946 DOI: 10.1007/s10620-020-06149-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
256 Benmassaoud A, Freeman SC, Roccarina D, Plaz Torres MC, Sutton AJ, Cooper NJ, Iogna Prat L, Cowlin M, Milne EJ, Hawkins N, Davidson BR, Pavlov CS, Thorburn D, Tsochatzis E, Gurusamy KS. Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis. Cochrane Database Syst Rev 2020;1:CD013123. [PMID: 31978257 DOI: 10.1002/14651858.CD013123.pub2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
257 Demir B, Demir İ. Effects of Illness Perception on Self-Care Agency and Hopelessness Levels in Liver Transplant Patients: A Descriptive Cross-Sectional Study. Clin Nurs Res 2021;:10547738211036983. [PMID: 34362267 DOI: 10.1177/10547738211036983] [Reference Citation Analysis]
258 Payancé A, Silva‐junior G, Bissonnette J, Tanguy M, Pasquet B, Levi C, Roux O, Nekachtali O, Baiges A, Hernández‐gea V, Laouénan C, Lebrec D, Albuquerque M, Paradis V, Moreau R, Valla D, Durand F, Boulanger CM, Garcia‐pagan J, Rautou P. Hepatocyte microvesicle levels improve prediction of mortality in patients with cirrhosis. Hepatology 2018;68:1508-18. [DOI: 10.1002/hep.29903] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
259 Rohr-Udilova N, Tsuchiya K, Timelthaler G, Salzmann M, Meischl T, Wöran K, Stift J, Herac M, Schulte-Hermann R, Peck-Radosavljevic M, Sieghart W, Eferl R, Jensen-Jarolim E, Trauner M, Pinter M. Morphometric Analysis of Mast Cells in Tumor Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation. Hepatol Commun 2021;5:1939-52. [PMID: 34558826 DOI: 10.1002/hep4.1770] [Reference Citation Analysis]
260 Bauer M, Fuhrmann V, Wendon J. Pulmonary complications in liver disease. Intensive Care Med 2019;45:1433-5. [PMID: 31375864 DOI: 10.1007/s00134-019-05721-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
261 Attwell A, Han S, Kriss M. Endoscopic retrograde cholangiopancreatography and liver biopsy in the evaluation of elevated liver function tests after liver transplantation. World J Hepatol 2021; 13(1): 132-143 [PMID: 33584992 DOI: 10.4254/wjh.v13.i1.132] [Reference Citation Analysis]
262 Marzec I, Słowakiewicz A, Gozdowska J, Tronina O, Pacholczyk M, Lisik W, Fleming A, Durlik M. Pregnancy after liver transplant: maternal and perinatal outcomes. BMC Pregnancy Childbirth 2021;21:627. [PMID: 34530745 DOI: 10.1186/s12884-021-04104-w] [Reference Citation Analysis]
263 Thomsen MT, Høgh J, Knudsen AD, Jensen AMR, Gelpi M, Villadsen GE, Abazi R, Holland-Fischer P, Køber L, Clemmesen O, Krohn PS, Hillingsø J, Vilsbøll T, Biering-Sørensen T, Kofoed KF, Nordestgaard BG, Rasmussen A, Nielsen SD. The Danish comorbidity in liver transplant recipients study (DACOLT): a non-interventional prospective observational cohort study. BMC Gastroenterol 2021;21:145. [PMID: 33794793 DOI: 10.1186/s12876-021-01733-5] [Reference Citation Analysis]
264 Altieri M, Sérée O, Lobbedez T, Segol P, Abergel A, Blaizot X, Boillot O, Boudjema K, Coilly A, Conti F, Chazouillères O, Debette-Gratien M, Dharancy S, Durand F, Duvoux C, Francoz C, Gugenheim J, Hardwigsen J, Houssel-Debry P, Kamar N, Latournerie M, Lebray P, Leroy V, Neau-Cransac M, Pageaux GP, Radenne S, Salamé E, Saliba F, Samuel D, Vanlemmens C, Besch C, Launoy G, Dumortier J. Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients. Clin Res Hepatol Gastroenterol 2021;45:101514. [PMID: 33714907 DOI: 10.1016/j.clinre.2020.07.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
265 De Gasperi A, Zorzi A. Cardiac evaluation before liver transplantation: A step forward? J Hepatol 2021;75:19-21. [PMID: 33985819 DOI: 10.1016/j.jhep.2021.04.034] [Reference Citation Analysis]
266 Matteo MV, D'Oria M, Bove V, Carlino G, Pontecorvi V, Raffaelli M, Chieffo D, Cesario A, Scambia G, Costamagna G, Boškoski I. Personalized Approach for Obese Patients Undergoing Endoscopic Sleeve Gastroplasty. J Pers Med 2021;11:1298. [PMID: 34945770 DOI: 10.3390/jpm11121298] [Reference Citation Analysis]
267 Caraceni P, Abraldes JG, Ginès P, Newsome PN, Sarin SK. The search for disease-modifying agents in decompensated cirrhosis: From drug repurposing to drug discovery. J Hepatol 2021;75 Suppl 1:S118-34. [PMID: 34039483 DOI: 10.1016/j.jhep.2021.01.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
268 Han JW, Joo DJ, Kim JH, Rha MS, Koh JY, Park HJ, Lee JG, Kim MS, Kim SI, Shin EC, Park JY, Park SH. Early reduction of regulatory T cells is associated with acute rejection in liver transplantation under tacrolimus-based immunosuppression with basiliximab induction. Am J Transplant 2020;20:2058-69. [PMID: 31965710 DOI: 10.1111/ajt.15789] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
269 Marciano S, Mauro E, Giunta D, Torres MC, Diaz JM, Bermudez C, Gutierrez-Acevedo MN, Narvaez A, Ortíz J, Dirchwolf M, Pollarsky F, Rojas-Saunero LP, Gadano A. Impact of acute-on-chronic liver failure on post-transplant survival and on kidney outcomes. Eur J Gastroenterol Hepatol 2019;31:1157-64. [PMID: 31385871 DOI: 10.1097/MEG.0000000000001467] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
270 Colmenero J, Tabrizian P, Bhangui P, Pinato DJ, Rodríguez-Perálvarez ML, Sapisochin G, Bhoori S, Pascual S, Senzolo M, Al-Adra D, Herrero JI, Petrowsky H, Dawson LA, Hosni A, Kutzke JL, Gastaca M, Watt KD. De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management-Guidelines From the ILTS-SETH Consensus Conference. Transplantation 2022;106:e30-45. [PMID: 34905760 DOI: 10.1097/TP.0000000000003998] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
271 Hartl L, Elias J, Prager G, Reiberger T, Unger LW. Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease. World J Gastroenterol 2021; 27(19): 2281-2298 [PMID: 34040322 DOI: 10.3748/wjg.v27.i19.2281] [Reference Citation Analysis]
272 Kim JM, Joh JW, Yi NJ, Choi GS, Kim K, Lee KW, Suh KS. Predicting Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Liver Resection for Solitary Hepatocellular Carcinoma. J Gastrointest Surg 2020;24:2219-27. [PMID: 31482410 DOI: 10.1007/s11605-019-04363-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
273 Dumortier J, Besch C, Moga L, Coilly A, Conti F, Corpechot C, Bello AD, Faitot F, Francoz C, Hilleret MN, Houssel-Debry P, Jezequel C, Lavayssière L, Neau-Cransac M, Erard-Poinsot D, de Lédinghen V, Bourlière M, Bureau C, Ganne-Carrié N. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP IN LIVER TRANSPLANTATION. Clin Res Hepatol Gastroenterol 2021;:101774. [PMID: 34332131 DOI: 10.1016/j.clinre.2021.101774] [Reference Citation Analysis]
274 Cai X, Li R, Sheng C, Tao Y, Zhang Q, Zhang X, Li J, Shen C, Qiu X, Wang Z, Jiao Z. Systematic external evaluation of published population pharmacokinetic models for tacrolimus in adult liver transplant recipients. European Journal of Pharmaceutical Sciences 2020;145:105237. [DOI: 10.1016/j.ejps.2020.105237] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
275 Ravaioli M, Lai Q, Sessa M, Ghinolfi D, Fallani G, Patrono D, Di Sandro S, Avolio A, Odaldi F, Bronzoni J, Tandoi F, De Carlis R, Pascale MM, Mennini G, Germinario G, Rossi M, Agnes S, De Carlis L, Cescon M, Romagnoli R, De Simone P. Impact of MELD 30-allocation policy on liver transplant outcomes in Italy. J Hepatol 2021:S0168-8278(21)02166-8. [PMID: 34774638 DOI: 10.1016/j.jhep.2021.10.024] [Reference Citation Analysis]
276 Kahn J, Pregartner G, Avian A, Kniepeiss D, Müller H, Schemmer P. The Graz Liver Allocation Strategy-Impact of Extended Criteria Grafts on Outcome Considering Immunological Aspects. Front Immunol 2020;11:1584. [PMID: 32849538 DOI: 10.3389/fimmu.2020.01584] [Reference Citation Analysis]
277 Appenzeller-Herzog C, Hartleif S, Vionnet J. Clinical parameters and biomarkers predicting spontaneous operational tolerance after liver transplantation: A scoping review. Am J Transplant 2021. [PMID: 33783969 DOI: 10.1111/ajt.16585] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
278 Rodríguez S, Motta FD, Balbinoto Neto G, Brandão A. EVALUATION AND SELECTION OF CANDIDATES FOR LIVER TRANSPLANTATION: AN ECONOMIC PERSPECTIVE. Arq Gastroenterol 2020;57:31-8. [PMID: 32294733 DOI: 10.1590/S0004-2803.202000000-07] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
279 Miller ED, Abu-sbeih H, Chalasani NP. Drug-Induced Liver Injury in Older Adults. In: Pitchumoni CS, Dharmarajan T, editors. Geriatric Gastroenterology. Cham: Springer International Publishing; 2019. pp. 1-16. [DOI: 10.1007/978-3-319-90761-1_53-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
280 Iesari S, Mocchegiani F, Nicolini D, Benedetti Cacciaguerra A, Coletta M, Montalti R, Mandolesi A, Lerut J, Vivarelli M. Liver transplantation for metastatic wild‐type gastrointestinal stromal tumor in the era of molecular targeted therapies: Report of a first case. Am J Transplant 2019;19:2939-43. [DOI: 10.1111/ajt.15377] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
281 Schlegel A, Foley DP, Savier E, Flores Carvalho M, De Carlis L, Heaton N, Taner CB. Recommendations for Donor and Recipient Selection and Risk Prediction: Working Group Report From the ILTS Consensus Conference in DCD Liver Transplantation. Transplantation 2021;105:1892-903. [PMID: 34416750 DOI: 10.1097/TP.0000000000003825] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
282 Effenberger M, Kronbichler A, Bettac E, Grabherr F, Grander C, Adolph TE, Mayer G, Zoller H, Perco P, Tilg H. Using Infodemiology Metrics to Assess Public Interest in Liver Transplantation: Google Trends Analysis. J Med Internet Res 2021;23:e21656. [PMID: 34402801 DOI: 10.2196/21656] [Reference Citation Analysis]
283 Engelmann C, Sterneck M, Weiss KH, Templin S, Zopf S, Denk G, Eurich D, Pratschke J, Weiss J, Braun F, Welker MW, Zimmermann T, Knipper P, Nierhoff D, Lorf T, Jäckel E, Hau HM, Tsui TY, Perrakis A, Schlitt HJ, Herzer K, Tacke F. Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant Centers. J Clin Med 2020;9:E2352. [PMID: 32717978 DOI: 10.3390/jcm9082352] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
284 Pérez-Cameo C, Bilbao I, Lung M, Caralt M, Vargas V, Pont T, Nuvials X, Los-Arcos I, Castells L, Len O. Routine Bile Culture From Liver Donors as Screening of Donor-Transmitted Infections in Liver Transplantation. Liver Transpl 2020;26:1121-6. [PMID: 32289870 DOI: 10.1002/lt.25778] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
285 Kumagai J, Taida T, Ogasawara S, Nakagawa T, Iino Y, Shingyoji A, Ishikawa K, Akizue N, Yamato M, Takahashi K, Ohta Y, Hamanaka S, Okimoto K, Nakamura M, Ohyama H, Saito K, Kusakabe Y, Maruoka D, Yasui S, Matsumura T, Sugiyama H, Sakai Y, Mikata R, Arai M, Katsuno T, Tsuyuguchi T, Kato N. Clinical characteristics and outcomes of primary sclerosing cholangitis and ulcerative colitis in Japanese patients. PLoS One. 2018;13:e0209352. [PMID: 30571774 DOI: 10.1371/journal.pone.0209352] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
286 Mazerkina NA, Savateev AN, Gorelyshev SK, Mariashev SA, Beregovskaya SA, Konovalov AN. [Hepatopulmonary syndrome: a rare manifestation of cirrhosis in patient with diencephalic obesity and nonalcoholic fatty liver disease after surgery for craniopharyngioma]. Probl Endokrinol (Mosk) 2021;67:58-66. [PMID: 34766492 DOI: 10.14341/probl12723] [Reference Citation Analysis]
287 Gilbo N, Monbaliu D. Temperature and oxygenation during organ preservation: friends or foes? Curr Opin Organ Transplant 2017;22:290-9. [PMID: 28426449 DOI: 10.1097/MOT.0000000000000416] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
288 Guirguis RN, Nashaat EH, Yassin AE, Ibrahim WA, Saleh SA, Bahaa M, El-Meteini M, Fathy M, Dabbous HM, Montasser IF, Salah M, Mohamed GA. Impact of biliary complications on quality of life in live-donor liver transplant recipients. World J Hepatol 2021; 13(10): 1405-1416 [PMID: 34786175 DOI: 10.4254/wjh.v13.i10.1405] [Reference Citation Analysis]
289 Piai G, Miglioresi L, Valente G. Eradication of Hepatitis C After Liver Transplantion: Consequences for the Organization of the Transplant Patient's Follow-up. Transplant Proc 2017;49:671-3. [PMID: 28457368 DOI: 10.1016/j.transproceed.2017.02.040] [Reference Citation Analysis]
290 Wong TC, Fung JY, Cui TY, Lam AH, Dai JW, Chan AC, Cheung TT, Chok KS, Ng KK, Lo CM. Liver transplantation using hepatitis B core positive grafts with antiviral monotherapy prophylaxis. J Hepatol 2019;70:1114-22. [PMID: 30871981 DOI: 10.1016/j.jhep.2019.03.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 7.7] [Reference Citation Analysis]
291 Tan PS, Muthiah MD, Koh T, Teoh YL, Chan A, Kow A, Zheng Q, Kwon CHD, Lee GH, Lesmana CRA, de Villa V, Fung J, Lim K. Asian Liver Transplant Network Clinical Guidelines on Immunosuppression in Liver Transplantation. Transplantation 2019;103:470-80. [DOI: 10.1097/tp.0000000000002532] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
292 Ma AT, Therrien A, Giard JM, von Renteln D, Bouin M. Alcoholic liver disease is a strong predictor of colorectal polyps in liver transplant recipients. Endosc Int Open 2017;5:E918-23. [PMID: 28924600 DOI: 10.1055/s-0043-114660] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
293 Gong N, Jia C, Huang H, Liu J, Huang X, Wan Q. Predictors of Mortality During Initial Liver Transplant Hospitalization and Investigation of Causes of Death. Ann Transplant 2020;25:e926020. [PMID: 33273447 DOI: 10.12659/AOT.926020] [Reference Citation Analysis]
294 Alferink LJM, Oey RC, Hansen BE, Polak WG, van Buuren HR, de Man RA, Schurink CAM, Metselaar HJ. The impact of infections on delisting patients from the liver transplantation waiting list. Transpl Int 2017;30:807-16. [PMID: 28403563 DOI: 10.1111/tri.12965] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
295 Oey RC, van Tilburg L, Erler NS, Metselaar HJ, Spaander MCW, van Buuren HR, de Man RA. The Yield and Safety of Screening Colonoscopy in Patients Evaluated for Liver Transplantation. Hepatology. 2019;69:2598-2607. [PMID: 30767249 DOI: 10.1002/hep.30562] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
296 Ferrarese A, Cattelan A, Cillo U, Gringeri E, Russo FP, Germani G, Gambato M, Burra P, Senzolo M. Invasive fungal infection before and after liver transplantation. World J Gastroenterol 2020; 26(47): 7485-7496 [PMID: 33384549 DOI: 10.3748/wjg.v26.i47.7485] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
297 Zheng YX, Zhong X, Li YJ, Fan XG. Performance of scoring systems to predict mortality of patients with acute-on-chronic liver failure: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2017;32:1668-1678. [PMID: 28303605 DOI: 10.1111/jgh.13786] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
298 Bolondi G, Mocchegiani F, Montalti R, Nicolini D, Vivarelli M, De Pietri L. Predictive factors of short term outcome after liver transplantation: A review. World J Gastroenterol 2016; 22(26): 5936-5949 [PMID: 27468188 DOI: 10.3748/wjg.v22.i26.5936] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 33] [Article Influence: 7.3] [Reference Citation Analysis]
299 Canbolat IP, Adali G, Akdeniz CS, Bozkurt B, Ferah O, Bulutcu F, Yuzer Y, Tokat Y. Postoperative Myocardial Injury Does Not Predict Early and 1-Year Mortality After Living Donor Liver Transplantation. Transplant Proc 2019;51:2478-81. [PMID: 31474300 DOI: 10.1016/j.transproceed.2019.02.046] [Reference Citation Analysis]
300 Maurel P, Prémaud A, Carrier P, Essig M, Barbier L, Rousseau A, Silvain C, Causse X, Debette-Gratien M, Jacques J, Marquet P, Salamé E, Loustaud-Ratti V. Evaluation of Longitudinal Exposure to Tacrolimus as a Risk Factor of Chronic Kidney Disease Occurrence Within the First-year Post-Liver Transplantation. Transplantation 2021;105:1585-94. [PMID: 32639405 DOI: 10.1097/TP.0000000000003384] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
301 Vitale G, Gitto S, Campani C, Turco L, Baldan A, Marra F, Morelli MC. Biological therapies in patients with liver disease: are they really lifesavers? Expert Opin Biol Ther 2021;:1-18. [PMID: 34860629 DOI: 10.1080/14712598.2022.2013799] [Reference Citation Analysis]
302 Lim WH, Ng CH, Ow ZGW, Ho OTW, Tay PWL, Wong KL, Tan EXX, Tang SY, Teo CM, Muthiah MD. A systematic review and meta-analysis on the incidence of osteoporosis and fractures after liver transplant. Transpl Int 2021;34:1032-43. [PMID: 33835638 DOI: 10.1111/tri.13863] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
303 Michard B, Artzner T, Lebas B, Besch C, Guillot M, Faitot F, Lefebvre F, Bachellier P, Castelain V, Maestraggi Q. Liver transplantation in critically ill patients: Preoperative predictive factors of post-transplant mortality to avoid futility. Clin Transplant. 2017;31. [PMID: 28895204 DOI: 10.1111/ctr.13115] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
304 Trebicka J, Gu W, de Ledinghen V, Aubé C, Krag A, Praktiknjo M, Castera L, Dumortier J, Bauer DJM, Friedrich-Rust M, Pol S, Grgurevic I, Zheng R, Francque S, Gottfriedovà H, Mustapic S, Sporea I, Berzigotti A, Uschner FE, Simbrunner B, Ronot M, Cassinotto C, Kjaergaard M, Andrade F, Schulz M, Semmler G, Drinkovic IT, Chang J, Brol MJ, Rautou PE, Vanwolleghem T, Strassburg CP, Boursier J, Ferstl PG, Rasmussen DN, Reiberger T, Vilgrain V, Guibal A, Guillaud O, Zeuzem S, Vassord C, Lu X, Vonghia L, Senkerikova R, Popescu A, Margini C, Wang W, Thiele M, Jansen C. Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease. Gut 2021:gutjnl-2020-323419. [PMID: 33479052 DOI: 10.1136/gutjnl-2020-323419] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
305 Burra P, Germani G. Organ allocation for liver transplantation: One size does not fill all. Liver Transpl 2016;22:715-6. [PMID: 27028657 DOI: 10.1002/lt.24447] [Reference Citation Analysis]
306 Ma KW, Cheung TT. When to consider liver transplantation in hepatocellular carcinoma patients? Hepat Oncol. 2017;4:15-24. [PMID: 30191050 DOI: 10.2217/hep-2016-0010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
307 Bert J, Geerts A, Vanlander A, Abreu de Carvalho L, Degroote H, Berrevoet F, Rogiers X, van Vlierberghe H, Verhelst X. Up to 50% of portal vein thrombosis remains undiagnosed until liver transplantation. Clin Transplant 2020;34:e14107. [PMID: 33030231 DOI: 10.1111/ctr.14107] [Reference Citation Analysis]
308 Plotogea O, Ilie M, Sandru V, Chiotoroiu A, Bratu O, Diaconu C. Cardiovascular and Metabolic Consequences of Liver Transplantation: A Review. Medicina (Kaunas) 2019;55:E489. [PMID: 31443295 DOI: 10.3390/medicina55080489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
309 European Association for the Study of the Liver. European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370-398. [PMID: 28427875 DOI: 10.1016/j.jhep.2017.03.021] [Cited by in Crossref: 1805] [Cited by in F6Publishing: 1711] [Article Influence: 361.0] [Reference Citation Analysis]
310 Caicedo LA, Buitrago D, Thomas LS, Villegas JI, Duque M, Serrano O, Arrunategui AM, Restrepo JG, Echeverri GJ. Liver Transplantation for Unresectable Metastases from Colon Adenocarcinoma. Case Rep Gastroenterol 2016;10:808-13. [PMID: 28203128 DOI: 10.1159/000454984] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
311 Elkholy S, Mogawer S, Hosny A, El-Shazli M, Al-Jarhi UM, Abdel-Hamed S, Salah A, El-Garem N, Sholkamy A, El-Amir M, Abdel-Aziz MS, Mukhtar A, El-Sharawy A, Nabil A. Predictors of Mortality in Living Donor Liver Transplantation. Transplant Proc 2017;49:1376-82. [PMID: 28736010 DOI: 10.1016/j.transproceed.2017.02.055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
312 Nemeth N, Peto K, Magyar Z, Klarik Z, Varga G, Oltean M, Mantas A, Czigany Z, Tolba RH. Hemorheological and Microcirculatory Factors in Liver Ischemia-Reperfusion Injury-An Update on Pathophysiology, Molecular Mechanisms and Protective Strategies. Int J Mol Sci 2021;22:1864. [PMID: 33668478 DOI: 10.3390/ijms22041864] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
313 Patidar KR, Peng JL, Kaur H, Worden A, Kettler CD, Pike F, Buckley CA, Orman ES, Desai AP, Nephew LD, Kubal CA, Gawrieh S, Chalasani N, Ghabril MS. Severe Alcohol-Associated Hepatitis Is Associated With Worse Survival in Critically Ill Patients With Acute on Chronic Liver Failure. Hepatol Commun 2021. [PMID: 34860462 DOI: 10.1002/hep4.1874] [Reference Citation Analysis]
314 Lai Q, Iesari S, Melandro F, Mennini G, Rossi M, Lerut J. The growing impact of alpha-fetoprotein in the field of liver transplantation for hepatocellular cancer: time for a revolution. Transl Gastroenterol Hepatol 2017;2:72. [PMID: 29034345 DOI: 10.21037/tgh.2017.09.05] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
315 Bossen L, Gerussi A, Lygoura V, Mells GF, Carbone M, Invernizzi P. Support of precision medicine through risk-stratification in autoimmune liver diseases – histology, scoring systems, and non-invasive markers. Autoimmunity Reviews 2018;17:854-65. [DOI: 10.1016/j.autrev.2018.02.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
316 Burra P, Bizzaro D, Forza G, Feltrin A, Volpe B, Ronzan A, Feltrin G, Carretta G, D'Amico F, Cillo U, Germani G. Severe acute alcoholic hepatitis: can we offer early liver transplantation? Minerva Gastroenterol (Torino) 2021;67:23-5. [PMID: 33140622 DOI: 10.23736/S2724-5985.20.02778-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
317 Payancé A, Dioguardi Burgio M, Peoc'h K, Achahboun M, Albuquerque M, Devictor J, Chor H, Manceau H, Soubrane O, Durand F, Castera L, Bouattour M, Paradis V. Biological response under treatment and prognostic value of protein induced by vitamin K absence or antagonist-II in a French cohort of patients with hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2020;32:1364-72. [PMID: 31895908 DOI: 10.1097/MEG.0000000000001652] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
318 Higuera-de-la-Tijera F, Castro-Narro GE, Velarde-Ruiz Velasco JA, Cerda-Reyes E, Moreno-Alcántar R, Aiza-Haddad I, Castillo-Barradas M, Cisneros-Garza LE, Dehesa-Violante M, Flores-Calderón J, González-Huezo MS, Márquez-Guillén E, Muñóz-Espinosa LE, Pérez-Hernández JL, Ramos-Gómez MV, Sierra-Madero J, Sánchez-Ávila JF, Torre-Delgadillo A, Torres R, Marín-López ER, Kershenobich D, Wolpert-Barraza E. Asociación Mexicana de Hepatología A.C. Clinical guideline on hepatitis B. Rev Gastroenterol Mex 2021:S0375-0906(21)00061-6. [PMID: 34384668 DOI: 10.1016/j.rgmx.2021.04.002] [Reference Citation Analysis]
319 Åberg F. Quality of life after liver transplantation.Best Pract Res Clin Gastroenterol. 2020;46-47:101684. [PMID: 33158471 DOI: 10.1016/j.bpg.2020.101684] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
320 Russo FP, Ferrarese A, Zanetto A. Recent advances in understanding and managing liver transplantation. F1000Res. 2016;5. [PMID: 28105300 DOI: 10.12688/f1000research.8768.1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
321 Beekman L, Berzigotti A, Banz V. Physical Activity in Liver Transplantation: A Patient's and Physicians' Experience. Adv Ther 2018;35:1729-34. [PMID: 30328060 DOI: 10.1007/s12325-018-0797-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
322 Ponziani FR, Valenza V, Nure E, Bianco G, Marrone G, Grieco A, Pompili M, Gasbarrini A, Agnes S, Sganga G. Effect of liver transplantation on intestinal permeability and correlation with infection episodes. PLoS One 2020;15:e0235359. [PMID: 32589654 DOI: 10.1371/journal.pone.0235359] [Reference Citation Analysis]
323 Aravinthan AD, Barbas AS, Doyle AC, Tazari M, Sapisochin G, Cattral MS, Ghanekar A, Mcgilvray ID, Selzner M, Greig PD, Bhat M, Selzner N, Grant DR, Lilly LB, Renner EL. Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study. Transpl Int 2017;30:1140-9. [DOI: 10.1111/tri.13008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
324 Koch A, Trautwein C, Tacke F. [Acute liver failure]. Gastroenterologe 2017;12:507-17. [PMID: 32288842 DOI: 10.1007/s11377-017-0214-9] [Reference Citation Analysis]
325 Burra P, Zanetto A. Filling the gap between clinical trials and real life in the treatment of severe HCV recurrence after liver transplantation. Transpl Int 2017;30:239-42. [PMID: 28102906 DOI: 10.1111/tri.12917] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
326 Li L, Yang L, Dong C, Yang Q, Huang W, Liao T, Sun X. Psychosocial Assessment of Donors in Pediatric Living Donor Liver Transplantation: A Systematic Review. Transplant Proc 2021;53:3-15. [PMID: 32631582 DOI: 10.1016/j.transproceed.2020.02.150] [Reference Citation Analysis]
327 Behnam Sani K, Sawitzki B. Immune monitoring as prerequisite for transplantation tolerance trials. Clin Exp Immunol 2017;189:158-70. [PMID: 28518214 DOI: 10.1111/cei.12988] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
328 Costentin CE, Bababekov YJ, Zhu AX, Yeh H. Is It Time to Reconsider the Milan Criteria for Selecting Patients With Hepatocellular Carcinoma for Deceased-Donor Liver Transplantation? Hepatology 2019;69:1324-36. [DOI: 10.1002/hep.30278] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
329 Balaceanu A. Deep vein thrombosis during long-term surveillance of patients with liver transplantation. Ir J Med Sci 2019;188:1191-3. [DOI: 10.1007/s11845-019-01998-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
330 Sandal S, Chen T, Cantarovich M. The Challenges With the Cardiac Evaluation of Liver and Kidney Transplant Candidates. Transplantation 2020;104:251-8. [DOI: 10.1097/tp.0000000000002951] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
331 Ruiz P, Valdivieso A, Palomares I, Prieto M, Ventoso A, Salvador P, Senosiain M, Fernandez JR, Testillano M, Bustamante FJ, Gastaca M. Similar Results in Liver Transplantation From Controlled Donation After Circulatory Death Donors With Normothermic Regional Perfusion and Donation After Brain Death Donors: A Case-Matched Single-Center Study. Liver Transpl 2021. [PMID: 34455694 DOI: 10.1002/lt.26281] [Reference Citation Analysis]
332 Best LM, Freeman SC, Sutton AJ, Cooper NJ, Tng EL, Csenar M, Hawkins N, Pavlov CS, Davidson BR, Thorburn D, Cowlin M, Milne EJ, Tsochatzis E, Gurusamy KS. Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis. Cochrane Database Syst Rev. 2019;9:CD013103. [PMID: 31513287 DOI: 10.1002/14651858.cd013103.pub2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
333 Kim KD, Lee JE, Kim JM, Lee O, Hwang NY, Rhu J, Choi GS, Kim K, Joh JW. Cost-effectiveness and long-term outcomes of liver transplantation using hepatitis B core antibody-positive grafts with hepatitis B immunoglobulin prophylaxis in Korea. Clin Mol Hepatol 2021;27:603-15. [PMID: 34492755 DOI: 10.3350/cmh.2021.0137] [Reference Citation Analysis]
334 Javanbakht M, Mashayekhi A, Trevor M, Branagan-harris M, Atkinson J. Cost-utility analysis of normothermic liver perfusion with the OrganOx metra compared to static cold storage in the United Kingdom. Journal of Medical Economics 2020;23:1284-92. [DOI: 10.1080/13696998.2020.1804391] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
335 Burra P, Giannini EG, Caraceni P, Ginanni Corradini S, Rendina M, Volpes R, Toniutto P. Specific issues concerning the management of patients on the waiting list and after liver transplantation. Liver Int 2018;38:1338-62. [PMID: 29637743 DOI: 10.1111/liv.13755] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
336 Cheng D, Zhuang Y, Kou Q, Zhang M, Zhao Y, Han C, Li J, Wang Y, Xu K, Mo F, Zhang J. Numerical simulation of hemodynamics in membranous obstruction of the suprahepatic inferior vena cava based on a subject-specific Budd-Chiari syndrome model. Clin Biomech (Bristol, Avon) 2018;52:20-4. [PMID: 29316476 DOI: 10.1016/j.clinbiomech.2017.12.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
337 Grancini V, Resi V, Palmieri E, Pugliese G, Orsi E. Management of diabetes mellitus in patients undergoing liver transplantation. Pharmacol Res. 2019;141:556-573. [PMID: 30690071 DOI: 10.1016/j.phrs.2019.01.042] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
338 Boggi U, Vistoli F, Andres A, Arbogast HP, Badet L, Baronti W, Bartlett ST, Benedetti E, Branchereau J, Burke GW 3rd, Buron F, Caldara R, Cardillo M, Casanova D, Cipriani F, Cooper M, Cupisti A, Davide J, Drachenberg C, de Koning EJP, Ettorre GM, Fernandez Cruz L, Fridell JA, Friend PJ, Furian L, Gaber OA, Gruessner AC, Gruessner RWG, Gunton JE, Han DJ, Iacopi S, Kauffmann EF, Kaufman D, Kenmochi T, Khambalia HA, Lai Q, Langer RM, Maffi P, Marselli L, Menichetti F, Miccoli M, Mittal S, Morelon E, Napoli N, Neri F, Oberholzer J, Odorico JS, Öllinger R, Oniscu G, Orlando G, Ortenzi M, Perosa M, Perrone VG, Pleass H, Redfield RR, Ricci C, Rigotti P, Paul Robertson R, Ross LF, Rossi M, Saudek F, Scalea JR, Schenker P, Secchi A, Socci C, Sousa Silva D, Squifflet JP, Stock PG, Stratta RJ, Terrenzio C, Uva P, Watson CJE, White SA, Marchetti P, Kandaswamy R, Berney T. First World Consensus Conference on pancreas transplantation: Part II - recommendations. Am J Transplant 2021. [PMID: 34245223 DOI: 10.1111/ajt.16750] [Reference Citation Analysis]
339 Rashidi-Alavijeh J, Straub K, Achterfeld A, Wedemeyer H, Willuweit K, Herzer K. Safety and efficacy of tenofovir alafenamide in liver transplant recipients: A single center experience. Transpl Infect Dis 2021;23:e13522. [PMID: 33217163 DOI: 10.1111/tid.13522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
340 Beckmann S, Drent G, Ruppar T, Nikolić N, De Geest S. Pre- and post-transplant factors associated with body weight parameters after liver transplantation – A systematic review and meta-analysis. Transplantation Reviews 2019;33:39-47. [DOI: 10.1016/j.trre.2018.10.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
341 Gustot T, Moreau R. Acute-on-chronic liver failure vs. traditional acute decompensation of cirrhosis. J Hepatol. 2018;69:1384-1393. [PMID: 30195459 DOI: 10.1016/j.jhep.2018.08.024] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
342 Jansen C, Cox A, Schueler R, Schneider M, Lehmann J, Praktiknjo M, Pohlmann A, Chang J, Manekeller S, Nickenig G, Berlakovich G, Strassburg CP, Hammerstingl C, Staufer K, Trebicka J. Increased myocardial contractility identifies patients with decompensated cirrhosis requiring liver transplantation. Liver Transpl 2018;24:15-25. [PMID: 28834154 DOI: 10.1002/lt.24846] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
343 Barone M, Viggiani MT, Losurdo G, Principi M, Leandro G, Di Leo A. Systematic review with meta-analysis: post-operative complications and mortality risk in liver transplant candidates with obesity. Aliment Pharmacol Ther. 2017;46:236-245. [PMID: 28488418 DOI: 10.1111/apt.14139] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
344 Liu K, Strasser SI, Koorey DJ, Leong RW, Solomon M, McCaughan GW. Interactions between primary sclerosing cholangitis and inflammatory bowel disease: implications in the adult liver transplant setting. Expert Rev Gastroenterol Hepatol 2017;11:949-60. [PMID: 28627935 DOI: 10.1080/17474124.2017.1343666] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
345 Samji NS, Heda R, Satapathy SK. Peri-transplant management of nonalcoholic fatty liver disease in liver transplant candidates . Transl Gastroenterol Hepatol 2020;5:10. [PMID: 32190778 DOI: 10.21037/tgh.2019.09.09] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
346 Kang SH, Cho H, Cho EJ, Lee JH, Yu SJ, Kim YJ, Yi NJ, Lee KW, Suh KS, Yoon JH. Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence. J Korean Med Sci 2018;33:e283. [PMID: 30402048 DOI: 10.3346/jkms.2018.33.e283] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]